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ABSTRACT

DEVELOPMENT AND EVALUATION OF A BIOCOMPATIBLE
ELECTROACTIVE SENSOR FOR CONTINUOUS BLOOD PRESSURE
MEASUREMENT
Scott Douglas Cambron
March 29, 2017
Piezo-active composites have been implemented for sensing and transduction for
decades. The 0-3 ceramic/polymer composite is one of the most common composite types
used for sensing applications, owing to their tailorable properties of the two-phase
composition, consisting of a three-dimensionally connected polymer/rubber matrix
(inactive phase) with a dispersion of isolated piezo-ceramic particles (active phase).
This thesis describes a method to develop novel biocompatible perivascular band
comprised of a two-phase piezo-active composite to be fabricated using simple
manufacturing processes. Biomaterials such as tissue scaffolds comprised of silk fibroin
(SF) and chitosan (CS), and biocompatible soft rubbers will be implemented as the three
dimensional inactive matrix, while a biocompatible piezo-ceramic nanoparticle such as
Zinc Oxide (ZnO) will be pursued as the piezo-active ceramic particles. Two compositions
were pursued, 1.) a biocompatible/biodegradable approach consisting of tissue scaffold
v

(SFCS) and ZnO particle formulation and 2.) a biocompatible soft rubber and ZnO particle
formulation. Test samples were fabricated using aforementioned formulations and tested
on a custom built dynamic biaxial testing apparatus to correlate mechanical strain to
piezoelectric output correlation.
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CHAPTER 1:

INTRODUCTION

Cardiovascular disease is the leading cause of death for both men and women in
America. Approximately 600,000 Americans die from heart disease each year (1 in every
4 deaths) [1] [2] [3]. Blood pressure is the internal pressure of the circulating blood pushing
against the arterial walls, which is pumped from the heart to the rest of the body within the
systemic cardiovascular loop. This systemic arterial pressure (SAP) normally rises and falls
throughout the day depending on levels of exertion. Normal resting blood pressure in
adults is approximately 120/80 mmHg. Systemic hypertension or high blood pressure
(HBP) (typically 140+/90+ mmHg) increases a person’s risk of cardiovascular disease.
Nearly 70 million Americans currently have HPB (1 in every 3 adults) which contributed
to more than 360,000 American deaths in 2013 [4].
The pulmonary loop of the cardiovascular system carries deoxygenated blood from
the right side of the heart, to the lungs and returns oxygenated blood back to the left side
of the heart, only to then return to the systemic loop through the aortic valve. The
pulmonary loop is significantly shorter than the systemic, therefore the resting pulmonary
arterial pressure (PAP) is normally much lower than SAP. Normal resting PAP in adults
is approximately 20/8 mmHg [6]. Pulmonary hypertension (PH) occurs when the pressure
in the blood vessels leading from the heart to the lungs within the pulmonary loop is
abnormally high (typically 30+/12+ mmHg), resulting in a narrowing of the arteries in the
lungs, reducing blood flow, subsequently reducing oxygenation of blood. Pulmonary
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hypertension is a rare, devastating disease in which HPB in the pulmonary arteries can lead
to right heart failure [7]. The number of PH related deaths and hospitalizations have
significantly increased from 15,500 and 260,000 respectively in 2001 to 21,250 and
405,000 respectively in 2010, a 36.5% and 96.7% increase respectively [8]. Ideal medical
management requires regular PAP monitoring.
Measurement of systemic blood pressure has been utilized by the medical field
since the mid-18th century. In 1733, Reverend Stephen Hales first measured blood pressure
by inserting tubes directly into the arteries of animals [9]. Riva Rocci, an Italian physician,
developed the first conventional cuff based sphygmomanometer in 1896, when later in
1905, Nicolai Korotkoff described various sounds while auscultating over the brachial
artery during deflation of a Rocci style cuff. Later coined Korotkoff Sounds, are used to
determine the systolic and diastolic blood pressures.

The combination of these 2

noninvasive techniques is still employed today and is considered the gold standard in the
medical field for accurate intermittent noninvasive systemic blood pressure measurement
[10]. Other noninvasive BP measurement approaches have been implemented in recent
years. The oscillometric method employs a sphygmomanometer cuff, similar to the
auscultatory method, but with an electronic pressure sensor to monitor cuff pressure
oscillations [10]. This method employs proprietary algorithms for calculating systemic
systolic and diastolic blood pressure values. Similar to the auscultatory method, the
oscillometric method can only record intermittent blood pressure measurements. As of
late, systems similar to the CNAP Monitor 500 HD (CN Systems, Austria), a continuous
noninvasive hemodynamic monitoring system, have been implemented primarily for
surgical procedures such as cesarean section, orthopedic, laparoscopic and vascular surgery
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[11]. All of the blood pressure measurement devices/systems mentioned above can and
will only measure the SAP of the cardiovascular system.
The most accurate method and the gold standard of measuring SAP is intra-arterial
pressure measurement.

An invasive surgical procedure where a catheter based

hydraulically coupled pressure sensor is typically inserted via radial (wrist), brachial
(elbow), femoral (groin), or dorsalis pedis artery (foot). This measurement system allows
for continuous SAP monitoring.
Pulmonary arterial pressure cannot be accurately measured via any noninvasive
technique.

Echocardiography has been pursued as an avenue of noninvasive PAP

measurement but has yet to yield repeatable and reliable results [12]. Intra-arterial PAP
measurement, otherwise known as right heart catheterization is considered the gold
standard, and currently the only reliable method of PAP measurement.

The

CardioMEMSTM HF wireless measurement system, recently FDA approved (June 2014),
is capable of monitoring PAP via a capacitive pressure sensor. Intra-arterial pressure
measurement being highly accurate can have negative attributes to overcome such as risk
of post-op infection. In the case of the CardioMEMSTM device, migration of device further
into the pulmonary system potentially causing an embolism is possible as well as the
possibility of post-op infection.
A device that can measure arterial pressure of a vessel without penetrating the
vessel wall would be beneficial, devoid of any cardiovascular issues of foreign objects
being in the blood stream for an extended amount of time, such as thrombosis or pulmonary
embolism.
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Purpose of Study
The overall goal of this project is to design, develop, characterize and
experimentally test an electroactive banding device consisting of organic and/or inorganic
materials such as silk fibroin, chitosan, and zinc oxide particles. The studies presented in
this work will focus on: 1.) developing a recipe for manufacturing a material comprised of
the ingredients previously listed that can withstand the strain generated by the distension
of the pulmonary artery during normal and elevated cardiovascular function, 2.)
determining the mechanical properties of said material via ASTM and or ISO standard
testing procedures, 3.) determining an association between local mechanical strain and
piezoelectric response of the biodegradeable electroactive material, and 4.) designing a
band like geometry to be placed around a porcine pulmonary artery ex vivo, properly
secured and evaluated on a custom built vascular distension simulation rig.

Specific Aims
The specific aims for this project are:
Specific Aim 1:

Develop compositions to create moldable biocompatible

electroactive piezo-composite (0-3) materials. Organic and inorganic materials such as
silk fibroin (Bombyx mori silkworm), high molecular weight chitosan, and zinc oxide
particles will be implemented to produce a band like structure that will be designed to
withstand the stresses and strains experienced during distension.
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Specific Aim 2:

Determine mechanical properties of the electroactive

composite(s). Following ASTM and or ISO standard procedures, mechanical properties
such as elastic modulus, tensile strength, elongation (ASTM D412-06a, ASTM D638-14,
ASTM D882-12), and viscoelasticity (ASTM-E328-02, ASTM-D2990-09) will be
determined using the eXpert 4000 MicroTest System (Admet, ).
Specific Aim 3:

Determine the correlation between mechanical strain and

electrical response of the biocompatible electroactive composite material.

The

piezoelectric performance of the device will be determined using two different
experimental methods: 1.) dynamic testing to apply mechanical strain to the sample; and,
2.) dynamic expansion of an engineered tubular structure by means of a custom vessel
distension simulation system, where the fabricated device would be attached or adhered.
Specific Aim 4: Benchtop ex vivo testing of porcine arterial tissue. Apply dynamic
expansion of porcine pulmonary arterial tissue by means of a custom vessel distension
simulation system, where the fabricated device would be attached or adhered around the
perimeter of the vessel.
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Significance of Study
In this project, an electroactive 0-3 connectivity piezo-composite sensing device
will be developed and fabricated. This device will be comprised of silk fibroin, chitosan,
and zinc oxide particles.
This project aims to generate a supplementary viable solution for measuring
continuous or real time in vivo pulmonary arterial pressure by developing a compliant
electroactive band that will circumscribe the vessel and monitor internal arterial pressure
by correlating the circumferential and lateral strains to the electroactive devices response.
To date, this type of 0-3 connectivity piezo-composite device for continuous in vivo
pulmonary arterial pressure has not been reported.
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CHAPTER 2:

BACKGROUND

Cardiovascular Anatomy, Physiology and Disease Review
The Cardiovascular System
The cardiovascular system consists of three primary components, 1.) blood – the
biofluid that circulates throughout the body carrying oxygen and nutrients to vital organs
and cells, 2.) vasculature – the conduit through which the blood flows and 3.) heart – the
pump that drives the flow of the blood through the vasculature [13]. Often referred to as
the circulatory system, blood follows a circular path through the body. The general pattern
of the circulatory blood flow is shown in Figure 2.1 and comprises of two loops: the
pulmonary loop consisting of all vasculature within the lungs and those connecting the
heart to the lung, and the systemic loop which includes the vasculature of the rest of the
body. The pulmonary loop of the cardiovascular system carries deoxygenated blood (blue
in Figure 2.1) from the right side of the heart, to the lungs and returns oxygenated blood
(red in Figure 2.1) back to the left side of the heart, only to then return to the systemic loop
through the aortic valve to then be pumped to the rest of the body [13] [14].
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Figure 2.1. Illustration of the cardiovascular system, displaying the pulmonary and
systemic flow circuits. [9]

Cardiovascular Disease and Heart Failure
Cardiovascular disease is the leading cause of death in both men and women in
America. Approximately 600,000 Americans die from heart disease each year (1 in every
4 deaths) [3] [4]. Heart failure is typically the final path of most chronic cardiovascular
diseases. In 2005, Approximately 6 million Americans are currently living with heart
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failure, of those, approximately 25% had advanced or end stage heart failure (ESHF) [15].
Advanced forms of heart failure typically involve transplantation of the heart for patients
who are eligible. Ineligible patients whether due to age or other health problems are
typically given a ventricular assist device (VAD) that can potentially extend the life of the
patient [16].

Ventricular Assist Devices
The introduction of the ventricular assist device in the 1980’s alongside the advances in
cardiac transplantation, VADs were used for the salvage of patients with advanced heart
failure accompanied by shock and multiple organ dysfunction, with the goal of future heart
transplantation [15]. Traditionally a Left Ventricular Assist Device (LVAD) is employed
to assist the left side of the heart (as an unloading mechanism) in pumping oxygenated
blood through the systemic circuit, connecting the inflow cannula of the pump to the apex
of the left ventricle and the pump outlet to the outflow cannula in the ascending aorta
(Figure 2.2a). Right Ventricular Assist Devices (RVAD) are typically employed to assist
the right side of the heart in pumping deoxygenated blood through the pulmonary circuit
[17], the inflow cannula channels blood from the right ventricle to the pump, and the
outflow cannula channels blood from the pump to the pulmonary artery (Figure 2.2b).
It is common for VAD patients to develop HBP; physicians overseeing patients
with implanted VADs will attempt to maintain normal blood pressure, by adjusting pump
performance in combination with prescribing HBP medication [18].

The VAD

performance adjustments are typically made while in the heart/device specialist office
while closely monitoring BP.
9

Figure 2.2. Examples of ventricular assist devices a.) Left Ventricular Assist Device
LVAD, b.) Right Ventricular Assist Device RVAD [13]

The Baroreflex
In a healthy cardiovascular system, BP is stabilized and kept near homeostasis with
the assistance of the baroreflex [19]. This reflex is initiated by a series of internal pressure
sensors termed baroreceptors, which are primarily located within the large arteries of
thoracic and neck regions (i.e. carotid, aorta, and pulmonary artery) that sense the rapid
change in blood pressure via distension of the blood vessel and sending that signal to the
nervous system to make the desired adjustment to rapidly raise or lower SAP and/or PAP.
This baroreflex is ineffective in patients with VADs, there is currently no feedback
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mechanism that actively monitors BP and communicates said rapid changes to the VAD
for immediate adjustment.

Blood Pressure and Hypertension
Blood pressure (BP) is the internal pressure of the circulating blood pushing against
the vessel walls, which is pumped from the heart to the rest of the body within the systemic
loop [19]. This systemic arterial pressure (SAP) normally rises and falls throughout the
day depending on levels of exertion. Normal resting BP in adults is approximately 120/80
mmHg (Table 2.1). Systemic hypertension or high blood pressure (HBP) (typically
140+/90+ mmHg) increases a person’s risk of cardiovascular disease. Patients with SAP
or left heart related heart failure will typically have a Left Ventricular Assist Device
(LVAD) implanted to assist in pumping blood through the systemic loop [17]. Maintaining
a stable systemic BP is critical for proper cardiovascular and other vital organ function
throughout a healthy body.

Table 2.1. Normal and Hypertensive Systemic and Pulmonary Loop Blood Pressure
Values [14]
Systemic Loop

Pulmonary Loop

UNITS
mmHg

Normal

Hypertensive

Normal

Hypertensive

Systolic

90-140

140+

20-30

30+

Diastolic

60-90

90+

8-12

12+

Mean

70-100

100+

25

25+
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The pulmonary loop is significantly shorter than the systemic loop; therefore the
resting pulmonary arterial pressure (PAP) is normally much lower than SAP. Normal
resting PAP in adults is approximately 20/8 mmHg [8]. Pulmonary hypertension (PH)
occurs when the pressure in the blood vessels leading from the heart to the lungs within the
pulmonary loop is abnormally high (typically 30+/12+ mmHg) shown in Table 2.1,
resulting in a narrowing of the arteries in the lungs, reducing blood flow, subsequently
decreasing oxygenation of blood. Pulmonary hypertension is a rare and devastating disease
in which HBP in the pulmonary arteries can lead to right heart failure [7]. The number of
PH related deaths and hospitalizations have significantly increased from 15,500 and
260,000 respectively in 2001 to 21,250 and 405,000 respectively in 2010, a 36.5% and
96.7% increase respectively [8]. Patients with PAP or right heart related heart failure will
typically have a RVAD implanted to assist in pumping blood through the pulmonary loop.
Pulse pressure (PP) is
𝑃𝑃 = 𝑆𝑃 − 𝐷𝑃

(1)

where the systolic pressure (SP) is the point of maximum pressure in the Systole Period of
ventricular contraction, forcing of blood into aorta and pulmonary artery, and the diastolic
pressure (DP) is the point of minimum pressure in the Diastole Period of ventricular
relaxation [13]. Figure 2.3 shows representative pulse pressure waveforms for normal SAP
and PAP.
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Figure 2.3. Representation of the pulse pressure waveform for the systemic loop (red)
and the pulmonary loop (black). (Redrawn from [16])

Arterial Wall Mechanics
Arterial stiffness plays an essential role in cardiovascular disease and end stage
heart failure. During HBP progression, SAP and or PAP increases, the arterial vessels
undergo remodeling, the vessel walls become thicker and the modulus of elasticity
increases [20] [21] [22]. Both changes considerably affect arterial stiffness. Figure 2.4
shows a general representation of changes in diameter within a vessel during changes in
pulse pressure. The amount of expansion depends on the mechanical condition of the
artery.
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DIASTOLE

SYSTOLE

dD

dS

Vessel Wall Cross Sectional Area

Diastolic Lumen Area
Stroke Change in Lumen Area (ΔA)

Figure 2.4. Schematic representation of change in diameter of arterial vessel during
change in pulse pressure

As an arterial vessel remodels with increased stiffness, there are measurable metrics for
evaluation, all of which are typically based upon the non-invasive measurement of vessel
diameters and lumen areas during the cardiac cycle via techniques such as ultrasound,
magnetic resonance imaging (MRI), and echo tracking [17]. Echo tracking devices can
accurately measure diameter (d) and the stroke change in diameter (Δd) of various large
arteries [23] [24]. Distension is the measurement of the change in vessel diameter

𝐷 = 𝑑𝑆 − 𝑑𝐷

(2)

where dS is the systolic diameter and dD is the diastolic diameter. The cross-sectional
distensibility coefficient (DC) is considered a determinant of stress of the vessel wall is the
relative change in lumen area for a given change in pressure
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𝐴𝑆 −𝐴𝐷

𝐷𝐶 =

𝐴𝐷 ×𝑃𝑃

(3)

where the AS is the systolic cross-sectional lumen area, AD is the systolic cross-sectional
lumen area and PP is the pulse pressure. Cross-sectional compliance coefficient is the
absolute change in lumen area for a given pulse pressure by

𝐴𝑆 −𝐴𝐷

𝐶𝐶 =

𝑃𝑃

(4)

The cross-sectional measurements can be implemented assuming the arterial vessels
predominantly change in diameter and not length during the cardiac cycle [25]. Peterson’s
Modulus is the inverse of distensibility and represents the ratio of stress to strain in terms
of the pulse pressure and measurable lumen area parameters [26]

1

𝐴𝐷 ×𝑃𝑃

𝐸𝑃 = 𝐷𝐶 =

𝐴𝑆 −𝐴𝐷

(5)

The elastic modulus of the arterial wall is denoted as

𝐸𝑖𝑛𝑐 =

3(1+

𝐴𝐷
)
𝑊𝐶𝑆𝐴

𝐷𝐶

(6)

where

𝑊𝐶𝑆𝐴 =

2
𝜋(𝑑𝑂
−𝑑𝐼2 )

4
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(7)

where dO is the outer diameter and dI is the inner diameter of the arterial vessel.
Circumferential strain is the measure of change in circumference of a vessel through
diastole and systole, which is equivalent to

𝜀𝐶 =

𝜋(𝑑+∆𝑑)
𝜋𝑑

=

𝑑𝑆 −𝑑𝐷

(8)

𝑑𝐷

where the changes circumference can be reduced to changes in diameter. Table 2.2 shows
measured systolic and diastolic lumen areas of healthy patients and patients with
pulmonary hypertension [21]. Distension and circumferential strain were calculated from
the measured lumen areas.

Table 2.2. Pulmonary arterial distension and circumferential strain in healthy patients
and patients with PH [18]
Systolic
Diastolic
Area (mm2) Area (mm2)
Healthy
Patient
PH during
exertion
PH at rest

ΔA

Δd

εc (%)

710

450

260

6.13

25.6

620

480

140

3.37

13.7

1070

850

220

4.01

12.2

The above-mentioned indices are a means of non-invasively quantifying the regional
arterial stiffness of a patient to determine the level of severity of arterial stiffness related to
hypertension and or other cardiovascular related diseases.
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Blood Pressure Measurement and Sensing Technologies
Measurement of systemic BP has been utilized by the medical field since the mid18th century. In 1733, Reverend Stephen Hales first measured BP by inserting tubes
directly into the arteries of animals [9]. Riva Rocci, an Italian physician, developed the first
conventional cuff based sphygmomanometer in 1896, when later in 1905, Nicolai
Korotkoff described various sounds while auscultating over the brachial artery during
deflation of a Rocci style cuff. Later coined Korotkoff Sounds, are still used to determine
the systolic and diastolic blood pressures.
Noninvasive Measurement Techniques
The combination of the two abovementioned noninvasive techniques is still
employed today and is considered the gold standard in the medical field for accurate
intermittent noninvasive systemic BP measurement [10].

Other noninvasive BP

measurement approaches have been implemented in recent years. The oscillometric
method employs a sphygmomanometer cuff, similar to the auscultatory method, but with
an electronic pressure sensor to monitor cuff pressure oscillations [10]. This method
employs proprietary algorithms for calculating systemic systolic and diastolic blood
pressure values. Similar to the auscultatory method, the oscillometric method can only
record intermittent blood pressure measurements. Recently, systems similar to the CNAP
Monitor 500 HD (CN Systems, Austria), a continuous noninvasive hemodynamic
monitoring system, have been implemented primarily for surgical procedures such as
cesarean section, orthopedic, laparoscopic and vascular surgery [11]. All of the blood
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pressure measurement devices/systems mentioned above can and will only measure the
SAP of the cardiovascular system.
Invasive Measurement Techniques
The most accurate method of measuring SAP is intra-arterial pressure
measurement.

An invasive surgical procedure where a catheter based hydraulically

coupled pressure sensor is typically inserted via radial (wrist), brachial (elbow), femoral
(groin), or dorsalis pedis artery (foot). This measurement system allows for continuous
SAP monitoring [27].
Cong et al developed an in vivo blood pressure monitoring system for small
laboratory animals such as rats for real time measurement to be employed in biomedical
and genetic research to identify genetic variation susceptibility to diseases such as
hypertension [28] [29]. This type of perivascular device is placed around the carotid artery
of a rat, a capacitive pressure sensor is immersed in silicone oil and continuously monitors
the systemic blood pressure (Figure 2.5). Figure 2.5 displays actual laboratory rat blood
pressure waveform recorded wirelessly with high fidelity and accuracy.

Figure 2.5. In vivo blood pressure cuff. [28]
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Figure 2.6. In vivo data from In vivo blood pressure cuff. [28]

Pulmonary arterial pressure cannot be accurately measured via any noninvasive
technique. Echocardiography and MRI have been pursued as avenues of noninvasive PAP
measurement but has yet to yield repeatable and reliable results [30]. Intra-arterial PAP
measurement, otherwise known as right heart catheterization is considered the benchmark,
and currently the only reliable method of PAP measurement [12]. The CardioMEMSTM
HF wireless measurement system, recently FDA approved (June 2014), is capable of
wireless monitoring PAP via a capacitive pressure sensor [7].
None of the aforementioned devices directly have the ability to act as a feedback
control sensor to mimic the functionality of the baroreceptors of a healthy human
cardiovascular and nervous systems.
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Introduction Piezo-Composites
Piezo Composites
Piezo-active composites have been implemented for sensing and transduction for
decades [31]. A traditional 2-phase composite is identified with a two number notation
“m-n,” where m represents the connectivity of the active phase and n for the inactive phase.
Figure 2.7 shows an array of possible connectivity configurations of piezocomposites
between active and inactive phases (i.e. piezo ceramic rods within polymer matrix
respectively, a 1-3 piezocomposite) [31] [32] [33].

Figure 2.7. Illustration displaying connectivity of piezocomposites. Active phase
(hatched cubes), inactive phase (white cubes) [31]

The 0-3 ceramic/polymer composite is one of the most common composite types used for
sensing applications, owing to their tailorable properties of the two-phase composition
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[31], consisting of a three-dimensionally connected polymer/rubber matrix (inactive phase)
with a dispersion of isolated piezo-ceramic particles (active phase), shown in Figure 2.8
[34]. The 0-3 composite can have a high range of mechanical flexibility depending on
whether a polymer or rubber is employed.

Figure 2.8. Illustration of a 0-3 composite [34]

Tissue Scaffolds
Tissue engineering arose in the early 1990s to address boundaries of tissue grafting
and repair [35]. There are a number of essential considerations when determining a suitable
scaffold material: 1.) biocompatibility allowing cells to adhere, function normally and
migrate onto and through the scaffold in order to proliferate, 2.) biodegradability
permitting the cells to produce their own extracellular matrix (ECM) over time to replace
the implanted scaffold without any toxic byproducts to effect other organs or functions, 3.)
mechanical properties analogous to the implanted scaffold anatomical site and also strong
enough to withstand physician handling during implantation, 4.) architecture primarily
having a highly porous interconnected structure to ensure cellular growth penetration and
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biofactor diffusion, and 5.) manufacturability being clinically and commercially viable
fabrication procedure [36]. The concept of a scaffold is to transplant biofactors such as
cells, genes and/or proteins, within the porous degradable scaffold to stimulate tissue
repair. The scaffold material and porous architecture play a significant role in tissue
regeneration by preserving tissue volume, providing temporary mechanical function, and
delivering biofactors. A successful scaffold should balance mechanical function with
biofactor delivery, providing a successive transition in which the regenerated tissue
assumes function as the scaffold degrades.
Silk fibroin (SF) is a natural fibrous protein employed in tissue scaffold applications
due to having high permeability to water and oxygen, cell adhesion and growth
characteristics, low inflammatory response and high tensile strength with flexibility [37]
[38] [39]. The Bombyx mori silkworm cocoon shown in Figure 2.9 is one source for silk
fibroin extraction.

Figure 2.9. Image of Bombyx mori silkworm, moth and cocoons.

Chitosan (CS) is a partially deacetylated product of chitin, a crystalline
polysaccharide found in crustaceans such as shellfish. This material has great potential as
a component within tissue scaffolds due to being nontoxic, biodegradable, and having
excellent wound healing characteristics [40] [41].
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The combination of the aforementioned biomaterials provides exceptional
chemical, architectural, and mechanical properties which can be implemented into a highly
porous tissue scaffold for tissue engineering applications. This porous scaffold could act
as the inactive n phase of a 0-3 piezocomposite.

Zinc Oxide Nanoparticles
Zinc Oxide (ZnO) nanoparticles are a class of engineered ceramic particles that
exhibit unique semiconducting and piezoelectric properties. The crystal structure of ZnO
can either be cubic zinc blende (Figure 2.10a) or hexagonal wurtzite (Figure 2.10b) where
each anion is surrounded by four cations at the corners of a tetrahedron. The natural and
most stable crystalline structure is the wurtzite configuration, having low symmetry
resulting in spontaneous polarization [42].

Wurtzite

Zinc Blende

a.)

b.)

Figure 2.10. Illustration of a.) cubic zinc blende and b.) hexagonal wurtzite. Shaded gray
and black spheres represent Zn and O atoms, respectively [42].
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ZnO has high piezoelectric constants with electromechanical coupling, making it an
important material for piezo-transduction. ZnO also possesses excellent antibacterial,
antimicrobial, and biocompatible properties with no adverse effect on cellular function [41]
[43]. This engineered ceramic nanoparticle is a viable option as the active m phase of a 03 piezocomposite.
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CHAPTER 3:

MATERIALS AND METHODS

Instrumentation and Equipment
Laser Cutting System
The LS1630 laser cutting system (Boss Lasers, LLC, Sanford, FL,
www.bosslaser.com) consists of a 60W CO2 laser tube traversing over a 30 inch (X) by 16
inch (Y) honeycomb and knife blade material supporting platform (Figure 3.1). The X-YZ axis stage has an operational volume of 30.5 by 15.5 by 10 inches respectively with a
positioning resolution of 0.001 inches along all three axes. The Z axis has a contact based
linear potentiometer auto focus attachment that rapidly adjusts the distance between the
laser cutting head and material to be cut for optimal focal distance. While the system is in
operation and cutting materials such as sheet form of polymer, wood, or rubber, volatile
fumes and particulates are typically released from the material. They have to be safely
evacuated and/or filtered from the laser cutting enclosure. A 250 cubic foot per minute
(CFM) exhaust fan system is employed to vent the volatile fumes/particulates out of the
laser cutting system enclosure and safely into the building HVAC fume extraction system.
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Figure 3.1. Image of Boss LS1630 60 Watt CO2 laser cutting system.

Operation - File Generation
Design the desired structure of interest using SolidWorks or other computer-aided
design (CAD) package of choice. Import the 3D part file into a 2D drawing environment.
Save the 2D file as an Adobe Illustrator file (.AI), then open the .AI file in adobe illustrator
and immediately save it as .ai again. This procedure repairs a conversion issue generated
by the SolidWorks software within the *.AI file. Import .ai file into the RDWorks software.
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Operation - Laser Cutter
Turn on chiller. Home the laser head. Turn on laser cutter via key on top of enclosure near
integrated control panel. Open RD Works software. Manipulate imported .ai file in
RDWorks, creating an array of said part to generate an efficient nested group for cutting if
needed. Go to Handle > Cut Optimize to improve the order of cut operations between the
part features to be cut. Set cutting speed and laser power settings within the Work tab. A
power setting of 41% and cutting speed of 18 mm/s is utilized for cutting 3 mm thick
acrylic. Load material onto honeycomb material holding platform, tape edges down if
material does not maintain stable flatness. Position laser head to desired location over
material to be cut. Focus the laser head employing the auto focus attachment. Save
machine output file. Turn on exhaust blower and laser head compressor via surge protector
switch. Run the machine output file.

Custom Material Mixing System
The Tri-R Stir-R Model X63C 1/15 HP variable speed laboratory mixer (Tri-R
Instruments, Jamaica, NY) has a functioning range of 0 – 12,000 RPM (Figure 3.2a). This
device was utilized to mechanically mix the SFCS and SFCS-ZnO blends using a custom
made wire mixer head (Figure 3.2b) and modified laboratory spatula (Figure 3.2c). The
mixer was rigidly attached to the z-axis of a mechanical translation stage. To allow for
easy and precise placement of the mixer head within the sample vials.
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Figure 3.2. Image of Tri-R Stir-R Model X63C 1/15 HP variable speed laboratory mixer
with modified laboratory spatula mounted in the ¼ inch Jacobs chuck.

Viscometer
The LVDV-II+ Viscometer (Brookfield Ametek, Middleboro, MA) instrumented
with cone and plate configuration (CP-52) is employed to measure the viscosities of the
SFCS-ZnO blends. This device operates by applying shear on a fluid between the rotating
cone and the static plate, then measuring the rotational resistance exerted by the fluid.
Using preprogrammed algorithms, the viscometer hardware converts the resistance torque
to viscosity. A constant, controllable temperature of the cone and plate assembly is
maintained via the water jacketed assembly that is plumbed to a heated/refrigerated bath
and circulator (TC-500, Brookfield Ametek, Middleboro, MA; Figure 3.3).
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Figure 3.3. Cone and plate viscometer with water bath circulator.

Operation
Remove the cone from the viscometer spindle if one is mounted. Turn on the
viscometer (switch in rear) for the system to run an auto-diagnostic procedure with the
spindle unloaded. Mount the desired cone to the spindle when prompted by the viscometer
Graphical User Interface (GUI). The CP-52 is utilized for this investigation due to its broad
viscosity and shear rate range (Table 3.1).
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Table 3.1. Cone and plate viscometer parameter ranges.
Cone Spindle

CP-52

Shear Rate (s-1)

0 - 400

Viscosity Range (cP)

4.6 – 92,130

Sample Volume (mL)

0.5

SMC

9.83

SRC

2

The full scale viscosity range is given by:

𝜂𝑠 = 𝑇𝐾 ×𝑆𝑀𝐶 ×

10000
𝑅𝑃𝑀

(9)

where TK is the torque constant, equal to 0.03973 for the LVDV-II+, SMC is the spindle
multiplier constant, shown in Table 3.1, and RPM is the spindle rotational speed in
revolutions per minute. While the Shear Rate is calculated by:

𝑆𝑅 = 𝑆𝑅𝐶 × 𝑅𝑃𝑀

(10)

where SRC is the shear rate constant (Table 3.1). In order to determine the viscoelastic
characteristics of the SFCS-ZnO blends, sample measurements are taken at varying shear
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rates of 3, 6, 12, and 24 s-1, to determine the shear thinning phenomenon and nonNewtonian nature of the blends.

PH Meter
The pH and Electrochemistry Meter (Phi 570, Beckman Coulter Inc., Fullerton,
CA) measures the pH of a solution, indicating its acidity or alkalinity (Figure 3.4). The pH
meter has a detection range from 0.00 to 14.00 pH with a resolution of 0.01 and an accuracy
of ±0.01 pH. The pH meter measures the difference in electrical potential between a pH
sensing electrode and a reference electrode. pH measurements sare recorded fromfor the
pure SFCS blends, ZnO nanoparticle dispersions and SFCS-ZnO blends prior to fabrication
of the final tissue scaffold structures.

Figure 3.4. pH Meter
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pH measurements were recorded from the pure SFCS blends, ZnO nanoparticle dispersions
and SFCS-ZnO blends prior to fabrication of final tissue scaffold structures.

Lyophilization System
Upon blending of the SFCS-ZnO tissue engineered scaffold solution, in order to
achieve high porosity, the lyophilization or freeze drying process was implemented.
During freeze-drying, the sample is frozen using a -80°C freezer and then placed in glass
vacuum jars that are plumbed to a refrigerated vacuum chamber of the FreeZone Plus 4.5
Liter Cascade Console Lyophilization System (7751040, Labconco, Kansas City, MO;
Figure 3.5). A rotary vane vacuum pump (M8C Maxima™ C Plus, Fisher Scientific™)
evacuates the air from the chamber and an upright refrigerated stainless steel moisture
collector coil removes a maximum of 1.8 liters of water in 24 hours. The water in the frozen
samples sublimates from ice directly into water vapor and collects onto the cold collector
coil.
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Figure 3.5. FreeZone Plus 4.5 Liter Cascade Console Freeze Dry System

Operation
Verify that the vacuum chamber lid, drain tube cap and all vacuum jar chamber ports
are closed. Press the button labeled “auto” to initially enable the refrigeration system.
Once the temperature reaches -40°C in the collector coil, the vacuum pump engages and
pumps down until ~50 mTorr. Load frozen samples into vacuum jars and insert into the
chamber ports. Gradually open chamber port valves until the vacuum chamber pressure
stabilizes below 100 mTorr and maintain this pressure for at least 24 hours to allow for
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complete removal of water from the samples. Initiate the shutdown procedure by pressing
the “auto” button to disable the vacuum pump and refrigeration system. Purge the vacuum
chamber with atmospheric air and remove the samples from vacuum jars. Remove vacuum
chamber lid and drain tube cap. Place open drain tube into a 4 liter Erlenmeyer flask to
collect the melted ice from the collector coil and turn off the switch on right side of cabinet.

Digital-Control Water Bath
The fabricated SFCS-ZnO are samples suspended in phosphate buffered saline
(PBS) solution are placed water bath at 37°C to incubate the samples in 4 hour intervals,
replenishing the PBS in order to leach out any residual chemicals implemented in the
scaffold construction process. The IsoTemp 215 digital temperature-controlled water bath
(IsoTemp 215, Fisher Scientific, Hampton, NH; Figure 3.6), with an operating temperature
range from ambient to 100°C at a resolution of 0.1°C and thermal uniformity of ±0.24°C,
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is thermally controlled via PID closed loop feedback system. At a set temperature of 37°C,
the water bath has an increased accuracy and stability of ±0.5°C.

Figure 3.6. Image of IsoTemp 215 digital control water bath

Scanning Electron Microscope
The LEO Supra 35 variable pressure scanning electron microscope (VPSEM) (Carl
Zeiss, Oberkochen, Germany) was used to image the SFCS-ZnO scaffolds in this
investigation. The VPSEM has a nominal resolution of 1.7 nanometers at 15 kV, and a
nominal resolution of 2.0 nanometers at 30 kV in variable pressure (VP) mode (Figure 3.7).
It has a magnification range of 12x to 900,000x, and a VP vacuum range of 2 to 133 Pa in
steps of 1 Pa. The focused beam of electrons from the VPSEM impacts an electricallygrounded sample with a focused beam of electrons, which dislodge additional electrons
from the sample. While the beam scans the sample, the extricated electrons are collected
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and converted to representative topographical imagery with a resolution of approximately
2 nm.

Figure 3.7. Carl Zeiss LEO Supra 35VP Scanning Electron Microscope

Operation
Typically, SEM samples must be electrically conductive, thereby providing a
pathway for the bombarding of electrons to reach ground. The SFCS samples were
mounted to a custom laser cut acrylic platform for imaging the sample cross section (Figure
3.8) and then attached to the SEM stage with conductive carbon tape. Samples requiring
a high magnification are sputter coated with a thin layer of gold-palladium alloy to increase
conductivity. The sample door is sealed and the chamber evacuated to <7 X 10-5 Torr for
samples requiring high magnification. A potential of 2 - 10 kV was applied to drive the
electrons toward the sample at a working distance of approximately 8 mm from the gun
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aperture. The image was focused and raster scanned (nominal scan speed = 5) to produce
a high-quality image.

Figure 3.8. 3D rendering of custom lasercut SEM sample imaging array fixture

To reduce the overall time required to image a total of 27 SFCS-ZnO samples in the SEM;
each individual SFCS-ZnO sample was mounted to the custom lasercut acrylic 45° sample
holder to effectively and efficiently image the sliced cross sections, using the chart below
which identifies each specimen location (Table 3.2).
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Table 3.2. Layout map of SEM specimen fixture.
5050
30 nm
2%

5050
45 nm
2%

5050
200 nm
2%

3070
30 nm
2%

3070
45 nm
2%

3070
200 nm
2%

7030
30 nm
2%

7030
30 nm
5%

5050
30 nm
5%

5050
45 nm
5%

5050
200 nm
5%

3070
30 nm
5%

3070
45 nm
5%

3070
200 nm
5%

7030
45 nm
2%

7030
45 nm
5%

5050
30 nm
10%

5050
45 nm
10%

5050
200 nm
10%

3070
30 nm
10%

3070
45 nm
10%

3070
200 nm
10%

7030
200 nm
2%

7030
200 nm
5%

To reduce charging effects of the SFCS-ZnO samples, the custom sample holder was
strategically mounted with copper tape to generate a conductive path from the sputtered
SFCS-ZnO specimens to the grounded SEM stage (Figure 3.9).
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Figure 3.9. Image of SEM sample holder for capturing cross sections of lyopholized
SFCS-ZnO blends.

The SEM specimens were then placed on their corresponding locations with respect to the
sample layout map (Figure 3.10) and then sputtered to ensure minimal charging effects
during imaging.
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Figure 3.10. Image of SEM sample holder for capturing cross sections of lyopholized
SFCS-ZnO blends.
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Sputtering Machine
The benchtop sputtering machine (Quorum Technologies, Ltd., East Sussex,
England) is employed to deposit a uniform thickness thin film of gold-palladium (Figure
3.11).

Figure 3.11. DC Sputtering System for applying gold onto SFCS substrates.

Operation
Open the valve on the argon tank. Turn on the power to the sputtering machine
digital voltage meter. Place sample on platen and close lid. Turn the right most knob to
“Pump”. Once e thvacuum gauge reads 0.1 Torr or less, introduce Argon into the chamber
by turning the left most knob, the “Argon Leak Valve”, a full turn counter-clockwise. Once
the pressure levels reach 0.5 Torr, immediately close the valve. Turn right most knob to
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“Set HT” and slowly turn the center dial to increase the voltage to 1.4 kV. Turn the right
most knob to “Mode” and press “Timer” to start the timer as well as the sputtering process.
When the timer has stopped, the high voltage will disengage. Turn the right most knob to
“Pump”, close the “Argon Leak Valve”, decrease the voltage knob to zero, and turn the
unit off. Release vacuum on the chamber and open the lid to remove the sample.

Uniaxial Micro Tensile Tester System
A uniaxial micro tensile testing system (Admet Expert Microtester 4000, Admet,
Inc., Norwood, MA) is used to apply a uniaxial tension/compression loads to the small of
biomaterials. The unit is comprised of a heated fluid bath () with compatible temperature
controller (Omega Engineering, Stamford, CT), a 150 gram tension/compression load cell
(Honeywell Sensotech, Columbus, OH), an electromechanical linear actuator (Physik
Instrumente (PI), Auburn, MA), and the MTESTQuattro controller unit (Admet, Inc.,
Norwood, MA). The heated fluid bath reservoir is comprised of stainless steel and has a
100 cc fluid capacity. The bath is actively heated via two ceramic rod heating elements
embedded within the fluid bath reservoir housing body and controlled via a closed loop
PID feedback controller unit. The effective controllable temperature range is 27.0°C up to
70.0°C with a resolution of 0.1°C. The 150 gram tension/compression load cell is
constructed of stainless steel and has an accuracy, non-linearity and hysteresis of ±0.70%,
0.25%, and 0.5% of full scale, respectively. The load cell is submersible and mounted
directly to the fluid bath reservoir housing body. The linear actuator is driven by means of
a stepper motor and leadscrew assembly and has a 25 mm stroke with a positional
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repeatability of 0.1 μm and a maximum velocity of 50 mm/min. The MTESTQuattro is a
PC (Pavilion m7, Hewlett Packard, Palo Alto, CA) connected controller unit for the
mechanical testing system. The MTESTQuattro GUI provides connectivity and control to
all the electromechanical testing systems. The integrated analysis suite provides the
flexibility to perform tests in accordance to ASTM, ISO or custom user test specifications.

Figure 3.12. Admet eXpert 4000 Microtester alongside MTESTQuattro Controller, and
Omega Temperature Controller.

Operation
Log into the PC connected to the tensile testing system. Open the Expert 4000
Microtester software (MTESTQuattro-4000.exe) and wait for initialization. Turn the red
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button on top of the MTESTQuattro controller clockwise to enable the controller. Fill the
fluid bath with water via the plumbed 120 mL syringe, ensuring the Type K shrouded
thermocouple is submerged in the fluid bath. Open the temperature controller software
(Device Interface.exe) and set to COM2 and reconfigure. Turn on the temperature
controller unit that is programmed to a set point of 37°C. Run the test procedure titled
“Temp Settle”, for the programmed 1.5 hours to ensure that the temperature has stabilized
along with the temperature compensated load cell. Place a test sample in the heated bath
and allow to acclimate for at least 15 minutes. Mount the acclimatized ring sample in the
custom fabricated loop tensile grips. Run the desired test procedure. Note: Individual test
procedures will be discussed later in this chapter.

Electrodynamic Shaker, Amplifier, and Waveform Generator
The LW126.138-13 electrodynamic system (EDS) (Labworks, Inc, Costa Mesa,
CA; www.labworks-inc.com) is comprised of an electrodynamic shaker (ET-126-1; Figure
3.13a) and linear power amplifier, (PA-138; Figure 3.13b) and a supplemental function
generator (Model 33220A, Agilent Technologies, Santa Clara, CA). The permanent
magnet shaker generates a peak shock and sine wave force of 53 and 13 pounds,
respectively, producing a maximum displacement of 0.75 inches peak-to-peak at zero load.
The functional operating frequency range is from DC up to 8,500 Hertz. The power
amplifier electrically drives the shaker and can output up to 25 Volts rms and 20 Amps rms
with a maximum continuous power dissipation of 450 Watts. A function waveform
generator is employed to drive the electrodynamic shaker at a user defined waveform (i.e.
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sine, ramp, square wave) at a particular amplitude and frequency. A calibration curve iss
generated, correlating amplifier input voltage and measured shaker armature displacement.

Figure 3.13. Images of a.) electrodynamic shaker, b.) linear power amplifier, and
waveform generator.

Operation
Plug function generator into the PC (Pavilion m7, Hewlett Packard, Palo Alto, CA)
via a USB connection and turn the power on. Turn on the power amplifier and turn the
amperage control knob to the 9 o’clock position. Wait for the NI Function VISA software
to open. Plug in the USB cable from the NI-6353 USB DAQ card (National Instruments
Corporation, Austin, TX) into the PC. Select the desired waveform on the function
generator and push the output button to initiate shaker displacement.
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Keithley Source Measure Unit
A Source Measure Unit (SMU; Keithley 2410, Keithley Instruments, Cleveland,
OH) is a single-channel, DC parametric tester designed specifically for test applications
demanding coupled sourcing and measurement. The 2410 (Figure 3.14) is both a DC
power source (up to 1100V, 1A, or 20W) and a true instrument-grade multimeter (with
0.012% measurement accuracy). In operation, this instrument can act as a voltage source,
a current source, a voltage meter, a current meter, and an ohmmeter. The SMU is employed
to apply a DC electric field of up to 1 kV during the electrical poling process on the ZnO
nanoparticle filled composites.

Figure 3.14. Keithley 2410 Source Measure Unit

Hipotronics High Voltage DC Power Supply
A high voltage power supply (Hipotronics R30B High Voltage DC Power supply,
Hubbell Inc., Brewster, NY) is employed to pole the SFCS-ZnO blends. This high voltage
power supply (Hubbell Inc., Brewster, NY) has a maximum DC voltage of 30 kV and a
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maximum current of 50 μA. The Hipotronics supply is employed to apply a DC electric
field of up to 6 kV in during the electrical poling process on the ZnO nanoparticle filled
composites. The functional poling voltage applied to the SFCS-ZnO blends is between 3
and 6 kV.

Figure 3.15. Image of front panel of the Hipotronics R30B HV DC power supply.

High Voltage Probe and Measurement Setup
A high voltage probe (Fluke 80K-15, Fluke Corporation, Everett, WA) was
implemented for measuring the output of the high voltage power supply. This high voltage
probe (Figure 3.16) is rated up to 15 kV DC with an accuracy of ±2% and is typically used
in low energy applications. The probe is a precision 1000:1 voltage divider formed via two
matched resistors and can be simply plugged into a multimeter for an accurate readout. For
these experiments, the multimeter is set to measure the DC voltage (V), and for easy
conversion, the appropriate voltage range is set (i.e. 1 V reading per 1000 V input), then
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the HV measurements are performed with the attached probe and multiply the multimeter
reading by 1000 to retrieve the actual HV output.

Figure 3.16. Fluke HV Probe plugged into a multimeter.

Analog to Digital Conversion
The Multi-Function X Series USB data acquisition unit (USB-6353, National
Instruments Corp, Austin, TX) is implemented as the analog-to-digital (A/D) conversion
unit for this investigation (detailed technical specifications are outlined in the Appendix).
The unit shown in Figure 3.17 was inserted into the PC (Pavilion m7, Hewlett Packard,
Palo Alto, CA) running Windows 7 (Microsoft Corporation, Redmond, WA). The USB6353 A/D converts analog signals into an approximate digital representation at 16-bit (216
levels) resolution and at a maximum acquisition rate of 1,250,000 samples/second within
a maximum measurement range of ±10V. The 16-bit resolution determines the smallest
theoretical measurement level by the following relationship
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𝑉𝑜𝑙𝑡𝑎𝑔𝑒 𝑅𝑎𝑛𝑔𝑒
𝑉𝑚𝑎𝑥 − 𝑉𝑚𝑖𝑛
20 𝑉
=
=
= 0.0003052 𝑉⁄𝑠𝑡𝑒𝑝
16
𝐴⁄𝐷 𝑅𝑒𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛
2
65536 𝑠𝑡𝑒𝑝𝑠

where Vmax and Vmin are the maximum and minimum values of the measurement range,
+10 and -10 volts, respectively.

Figure 3.17. NI USB-6353 A/D converter

Custom Designed and Fabricated Devices and Instrumentation
Custom Electrodynamic Planar Shear Displacement Apparatus
Design Implemented in Investigation
With the purpose of reducing specimen slippage and damage during shear tests, the
custom electrodynamic planar shear displacement apparatus was designed and fabricated.
Mr. Grip Stripped Screw Hole Repair Kit friction electrode plates were mounted to the
laser-cut acrylic framework of the developed piece of equipment (Figure 3.18). A linear
potentiometer was employed to accurately measure the displacement of the moving
electrode of the electrodynamic shearing device. A 6-inch digital caliper was used to apply
a known displacement to the potentiometer while recording the voltage from the digital
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multimeter (Figure 3.19 Left). A calibration curve was plotted for displacement – response
of the linear potentiometer. Figure 3.19 (Right) demonstrates the linear relationship,
showing the slope and offset. This data was then input into the LabVIEW program to
directly convert change in the potentiometer voltage to displacement.

Figure 3.18. Image of the fabricated and assembled custom electrodynamic planar shear
displacement apparatus.
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Figure 3.19. (Left) Image of displacement application to the linear potentiometer and
(Right) Plot of Displacement – Potentiometer Output for position calibration.

Upon testing, the SFCS-ZnO disc specimens were loaded between the parallel electrodes
as shown in Figure 3.20. The top electrode in Figure 3.20 was fixed and the bottom
electrode was movable and attached to the electrodynamic shaker platen via an acrylic
block. The electrodes were wired directly into the differential amplifier before entering
data acquisition system for recording. A gauge block (not shown) was used to ensure a 2mm gap was set between the electrodes for each sample. The electrodes were mounted to
the frame via high bond double-sided adhesive (3M, Model #414/DC). Multiple layers
were added to the fixed electrode to account for fabrication and assembly errors to ensure
the proper electrode gap distance.
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Figure 3.20. Image of shear electrode assembly with 2 mm gap set.

Custom Electrodynamic Vessel Distension Simulation Apparatus
To mimic anatomical blood vessel distension a custom electrodynamic vessel
distension simulation simulation apparatus (EVDSA) is developed. A lasercut acrylic
frame (6.34 mm thick) is designed to mount directly to the EDS support and isolation
structure under the shaker unit. The EDS is oriented in a horizontal position and two legs
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are incorporated into the frame to level and stabilize the vessel distension unit (Figure
3.21).

Figure 3.21. 3D CAD rendering of vessel distension simulation system.

The secondary vessel attachment subassembly (VAS) is designed to incorporate an internal
closed volume where an engineered or anatomical blood vessel would be placed (Figure
3.22). The compliant vessel would attach to the barbed fittings on both ends of the
subassembly via clamps or zip ties to seal off the closed internal volume. The subassembly
is mounted into the test frame that is attached to the EDS.
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Figure 3.22 3D CAD rendering of the closed volume subassembly for mounting an
engineered or actual blood vessel.

A 12.7 mm diameter piston is fabricated from aluminum and mounted to the movable EDS
platen. The piston is enclosed and sealed via an o-ring within the cylinder block housing
of the VAS. With the fully assembled system and vessel mounted to barbed fittings, the
closed volume can be filled with saline solution via the fluid inlet and outlet luer fittings.

Figure 3.23. Cross Section View of a 3D CAD rendering of the vessel distension system.
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EVDSA Filling and Draining
Prior to filling, an inline pressure sensor (PRESS-S-000, PendoTECH, Princeton,
NJ) is mounted to the lower luer fitting. The pressure sensor is comprised of polycarbonate
with inlet and outlet luer fittings (Figure 3.25). It has an operating range of -362 mmHg to
3879 mmHg, with an accuracy better than ±2% of reading within a range of 0 to 300
mmHg. Stopcock valves are then mounted on each luer fitting and used to close off the
internal volume.

Figure 3.24. Image of PendoTECH luer style pressure sensor.

To effectively fill the internal volume of the test sample with incompressible saline,
the distal end of the EVDSA must be raised approximately 65 mm to allow for the
compressible air to be evacuated during the filling procedure. Both inlet and outlet
stopcock valves are opened. Saline is injected into the lower luer port shown in Figure
3.25. This inclined orientation allows for air to escape from the upper open luer port during
filling process. The internal volume is slowly filled using a 50 mL syringe, while gently
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squeezing the attached and sealed compliant tube, whether engineered or anatomical, to
assist in evacuation of air bubbles that may be trapped, until the saline begins to exit the
upper luer fitting.

Evacuate Air Out

Fluid Fill In

Block to Elevate for
assistance in air
bubble evacuation

Figure 3.25. Illustration of filling procedure to replace all incompressible air with
compressible saline.

The piston stroke of the EDS is programmatically controlled through the EDS with
a maximum stroke of 12.7 mm. This change in stroke induces a change in internal fluid
pressure to generate a desired dynamic pulse pressure waveform could be generated by
adjusting the EDS piston stroke alongside the static internal pressure.
After distension testing, to efficiently drain the internal volume of the tubular test
sample, the proximal end of the EVDSA is raised 65 mm to allow for the saline to be
displaced with air. Both inlet and outlet stopcock valves are opened and air is injected into
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the upper luer port. This declined orientation allows for the saline to drain from the lower
open luer port. The internal volume is slowly filled with air using a 50 mL syringe, while
gently squeezing the attached and sealed compliant tube to assist in the draining until the
saline completely empties from the lower luer fitting (Figure 3.26).

Air Fill In

Evacuate Fluid Out

Block to Elevate for
assistance in
draining fluid

Figure 3.26. Illustration of filling procedure to replace all incompressible air with
compressible saline.

Piezoelectric Poling System
Poling electrodes are designed and developed to ensure a consistent electric field is
applied across a constant SFCS sample thickness of 2 mm. Generating an electric field
strength up to 3 kV/mm. Figure 3.27 displays the polarization mold that is implemented
in the poling of SFCS-ZnO blends, comprising of a 7 layered stacked assembly. Custom
lasercut 80 X 80 X 6.3 mm acrylic base (a.) and top (g.) are used to ensure a uniform
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clamping force of the mold. Custom Ø75 X 1.8 mm PCB electrodes (b. and f.) are milled
using a CNC board milling machine. A custom lasercut 2 mm Delrin spacer (d.) is
implemented to control the electrode gap thickness SFCS-ZnO during poling.

g.

f.
e.
d.
c.

b.

a.

Figure 3.27. 3D rendering and exploded view of SFCS:ZnO polarization molds

There are two polarization configurations pursued in this investigation a low
voltage (≤ 1 Kv via Keithley) and a high voltage (up to 6 Kv via Hipotronics). Figure 3.28
displays the complete polarization setup with the Keithley SMU atop an acrylic enclosure
that is utilized as a protective shield during the high voltage poling procedures, the
polarization mold is shown within the protective enclosure. Figure 3.29 displays the
polarization configuration with the Hipotronics supply atop a benchtop fume hood with the
acrylic enclosure placed inside to act as a secondary layer of protection against
electrocution.
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Figure 3.28. Keithley 2410 Sourcemeter sitting atop an acrylic enclosure with poling
mold.
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Figure 3.29. Hipotronics HV DC Power Supply sitting atop an acrylic enclosure with
poling mold.

Custom Laser Cut Molds
Several custom laser cut molds are employed to assist in the fabrication of a
multitude of sample geometries for the SFCS blends for all experimental testing required
for this investigation. All of the planar molds were comprised of 1/8” thick acrylic and
assembled with 8-32 socket head cap screws.

Porosity and Water Absorption Mold
The samples for the porosity and water absorption experiments required a smaller
geometry to fit within the sample holders. In order to accommodate, a mold is fabricated
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to make SFCS samples that are 10 mm X 18 mm X 3 mm. An array of 9 total cavities fit
within the mold platform (Figure 3.30).

Figure 3.30. CAD rendering of coupon mold for porosity and water absorption samples

Shear Testing Mold
The samples for the electrical characterization via shear testing experiments require a flat
geometry to fit within the parallel plate electrode geometry of the testing rig. Thus, a new
disc mold is fabricated to make samples that have a diameter of 22 mm and 2 mm thick.
An array of 3 total cavities fit within the mold platform (Figure 3.31).
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Figure 3.31. CAD rendering of disc mold for shear testing samples

Ring Test and Perivascular Band Mold
The samples for the mechanical testing and perivascular band experiments require
an annular cylinder geometry to reduce the localized induced stresses caused by the grip
area during mechanical testing while also making the band-like structure capable of being
mounted to the simulated blood vessel. The samples dimensions are 20 mm outer diameter,
4 mm wall thickness, and 9.6 mm cylinder height. An array of 7 total cavities fit within
the circular mold platform (Figure 3.32). The perivascular band mold is also designed to
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accommodate for a stackable configuration. The circular mold is primarily developed so
the stacked molds (up to 4) would fit within a lyophilizer vacuum jar (Figure 3.33).

Figure 3.32. CAD rendering of ring mold for mechanical and distension testing samples
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Figure 3.33. CAD rendering of ring mold in stacked configuration

The polymethylmethacrylate (PMMA) ring molds were successfully manufactured
via lasercutting techniques and assembled using 8-32 fasteners. A series of assembled
molds were stacked by inserting the threaded ends of the 1 inch 8-32 socket head cap
screws into the hexagonal heads of the fasteners of the assembled mold below, as seen in
Figure 3.34a. This assembled mold stack was easily inserted and removed from the
lyophilizer vacuum jar and then separated to individual molds (Figure 3.34b).
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a.)

b.)

Figure 3.34. Left: Image of stacked configuration of ring molds, Right: Image of
individual mold.

Figure 3.35. Illustration describing metrology metrics of molded SFCS-ZnO ring
specimen.

Table 3.3 lists the critical feature specifications that the acrylic molds were manufactured
to.
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Table 3.3. List of featured designed dimensions within mold.
Mold Specification (mm)
Outer Diameter (Ø)

20.0

Wall Thickness (WT)

4.25

Height (H)

9.5

Engineered Blood Vessel Mold
Due to the lack of available off-the-shelf tubing that effectively simulate blood
vessel distension, primarily due to the tubing wall thickness and effective durometer
values, a custom mold is fabricated. The simulated blood vessel has an exposed outer and
inner diameter of 11mm and 7.75 mm, respectively, and an overall length of 95mm. The
custom tube is comprised of DragonSkin®10 Fast (Smooth-On, Macungie, PA), having a
ShoreA hardness of 10A, tensile strength of 475 PSI, and a 100% modulus of 22 PSI. This
material is typically used as a blood vessel simulant for flow models and training of
suturing techniques in cardiovascular surgery. Figure 3.36a illustrates the CAD model of
the overall mold, where Figure 3.36b shows the cross section of the mold, displaying the
inner channels that allow for the injection of the DragonSkin®. Figure 3.36c shows a
rendering of the molded part with a partial cross section, exhibiting the inner channels that
are cut away after the part has fully cured, leaving a simple tube of custom cross section
that can be cut to any desired length for testing.

66

a.

b.

c.
Figure 3.36. a. 3D CAD rendering of the assembled simulated blood vessel mold, b. a
cross section view of said mold, and c. 3D CAD rendering of the molded vessel with
cutaway view displaying the inner channel that flows elastomer resin into the annular
region of the mold
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Custom Amplification Electronics
A custom differential amplifier is developed to amplify the raw SFCS-ZnO sensor
output voltage signal so that it is within the maximum measurement range yet above the
minimum resolution of the A/D converter. A differential amplifier is an electronic
amplifier that amplifies the difference between the positive and negative analog input
voltages and can ideally be represented as;

+
− )
𝑉𝑜𝑢𝑡 = 𝐴𝐷 (𝑉𝑖𝑛
− 𝑉𝑜𝑢𝑡

(16)

where AD is the amplifier gain. The custom differential amplifier (schematic shown in
Figure 3.37) developed for this investigation can be divided into 3 primary categories:
amplification (Blue), gain adjustment (Red), and offset adjustment (Green).

Figure 3.37. Schematic of differential amplifier
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The amplification occurs across 2 stages:
operational amplifier.

1.) differential amplification and 2.) an

In the first stage, differential amplification employs an

instrumentation amplifier (AD620, Analog Devices, Norwood, MA) as shown in Figure
3.38.

Figure 3.38. Illustration of connection pinout for the AD620 instrumentation amplifier.

where the theoretical gain (AD) can be calculated using the relationship:

𝐴𝐷 =

49400
+1
𝑅𝐺

(17)

where RG is the gain resistor value that allows for the differential gain to be
programmatically adjusted with fine-tuning of one externally connected resistor. The
second stage employs an operational amplifier (TLC2201CP, Texas Instruments Inc.,
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Dallas, TX) in the non-inverting configuration (Figure 3.39). The theoretical gain (AO)
can be calculated as:

𝐴𝑂 =

𝑅2
+1
𝑅1

(18)

where R1 is the gain resistor value and R2 is the feedback resistor value.

Figure 3.39. Schematic of the TLC2201CP operational amplifier.

To have some level of adjustability in the amplifier, gain adjustment switches are
incorporated into the circuitry (red area in Figure 3.37). The differential amplification
stage (1) had a 2-position switch accounting for 2 individual gain resistor values while the
operational amplification stage (2) had a 4-position switch accounting for 4 individual gain
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resistor values. To determine the overall theoretical gain of the circuit, the current gain
values of each stage are in a cascaded series and are multiplied together as shown below;

𝐴𝑜𝑣𝑒𝑟𝑎𝑙𝑙 = 𝐴𝐷 ×𝐴𝑜

(19)

Table 3.4 displays each theoretical gain setting for each stage switch position. The total
theoretical gain is listed in the far right column.

Table 3.4. Listing of individual and overall gain settings for custom differential
amplifier.

STAGE 1
DIP
SWITCH
POSITION

STAGE 1
RESISTOR
VALUE
(Ω)

STAGE 1
GAIN
SETTING

STAGE 2
DIP
SWITCH
POSITION

STAGE 2
RESISTOR
VALUE
(Ω)

STAGE 2
GAIN
SETTING

OVERALL
GAIN
Aoverall

1

470

106.1

1

2200

3.2

340

1

470

106.1

2

10000

11

1167

1

470

106.1

3

56000

57

6048

1

470

106.1

4

100000

101

10717

2

1000

50.4

1

2200

3.2

161

2

1000

50.4

2

10000

11

554

2

1000

50.4

3

56000

57

2873

2

1000

50.4

4

100000

101

5090

A 100kΩ rotary potentiometer with linear output is implemented as the offset adjustment
for the circuit (green area in Figure 3.37). This potentiometer is used to manually offset
the stable static signal back to zero upon loading of a new sample between experiments.
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The concept of the differential amplifier circuit is laid out on a virtual breadboard in a
software package titled Fritzing (FHP, Fachhochschule Potsdam, Potsdam, Germany) prior
to prototyping on an actual breadboard, which enables the “build” of the circuit virtually
with actual off-the-shelf electronic components (Figure 3.40).

The actual prototype

breadboard is presented in Figure 3.41, with the 2 stage amplifiers (the two black DIP
socket components), the gain adjustment switches for stage 1 (the red component with 2
position switches) and stage 2 (the blue component with 4 position switches), and the offset
adjustment potentiometer (the large black knob) represented in the figure. The Fritzing
software also converts the virtual breadboard layout to a PCB layout (Figure 3.42), so the
designer can effectively click and drag to move the individual circuit components on the
virtual PCB to generate an efficient and organized populated layout. The size of the PCB
can be manually adjusted to suit the desired footprint of the circuit as well.

Figure 3.40. Rendering of layout for the breadboard configuration of the differential
amplifier.
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Figure 3.41. Differential amplifier in actual breadboard layout.

The Fritzing software also converts the virtual breadboard layout to a PCB layout (Figure
3.42).

The designer can effectively click and drag to move the individual circuit

components on the virtual PCB to generate an efficient and organized populated layout.
The size of the PCB can be manually adjusted to suit the desired footprint of the circuit as
well.

Figure 3.42. PCB layout of differential amplifier.
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Following assembly, the amplifier was mounted to a laser-cut acrylic frame for
stability and portability (Figure 3.43). The battery packs were then securely mounted to
the frame via zip ties.

Figure 3.43. Images of differential amplifier, (Top Left) Isometric view, (Top Right) Top
view, (Bottom) Front view

Actual gain values of the amplifier were determined via the following calibration
procedure. A function generator, set to a voltage of 100 mV peak-to-peak and a frequency
of 2 Hz, was wired into a dual stage voltage divider circuit consisting of two 1:10 divider
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circuits in series that generated an overall theoretical 1:100 voltage division (Figure 3.44).
This voltage divider was implemented to reduce the voltage output of the function
generator to better emulate the low voltage signal (µV range) that the test specimen had
outputted during preliminary experiments.

Figure 3.44. (Left) Rendering of voltage divider circuit for amplifier calibration drawn
vie Fritzingand (Right) Populated breadboard

This circuit was then wired directly into an oscilloscope for measurement of the
circuit output, reducing the input voltage of 100 mVpp through the divider down to 720
μV. This known circuit output was then inputted from the function generator into the
differential amplifier circuit to confirm the designed gain settings. Prescribed gain resistors
were adjusted via DIP switches on the amplifier and the actual voltage was measured
(VMEAS) via the oscilloscope and recorded. The actual gain settings of the amplifier were
calculated via the following relationship:
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𝐺𝐴𝐶𝑇𝑈𝐴𝐿 =

𝑉𝑀𝐸𝐴𝑆 (𝑉)
×1000000
720 (𝜇𝑉)

(20)

The measured voltage values and calculated gains were listed in Table 3.5. The percent
error was calculated and found to be within ±3.1% for each gain setting. This calibration
method gives certainty to the measured electrical response of the SFCS-ZnO specimens
that is amplified through the differential amplifier and recorded in LabVIEW.

Table 3.5. Theoretical and actual gain based on stage resistors and the measured voltage
at the amplifier.
STAGE 1
DIP
SWITCH
POSITION

STAGE 2
DIP
SWITCH
POSITION

STAGE 1
RESISTOR
VALUE (Ω)

STAGE 2
RESISTOR
VALUE (Ω)

GTHEOR

VMEAS

GACTUAL

%
Error

1

1

470

2200

340

0.252

350.0

3.1%

1

2

470

10000

1167

0.816

1133.3

-2.9%

1

3

470

56000

6048

4.28

5944.4

-1.7%

1

4

470

100000

10717

7.52

10444.4 -2.5%

2

1

1000

2200

161

0.116

161.1

-0.1%

2

2

1000

10000

554

0.388

538.9

-2.8%

2

3

1000

56000

2873

2.02

2805.6

-2.3%

2

4

1000

100000

5090

3.56

4944.4

-2.9%
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Methodology
Piezo Composite Formulation Using Tissue Scaffold Blends
Tissue Scaffold Blends
The tissue scaffold based piezo composite is comprised of silk fibroin, chitosan,
and ZnO nanoparticles.

Three blends of silk fibroin chitosan (SFCS) mixtures are

investigated in this study, the SF and CS are mixed by volume to generate 70:30 (70%:30%
by vol), 50:50 (50%:50% by vol) and 30:70 (30%:70% by vol) SF:CS. The SFCS blends
are employed as the inactive component of the piezocomposite. The following procedures
detail the overall processes for SF extraction and dissolution from Bombyx mori silk
cocoons (Figure 3.45).

Figure 3.45. Illustration of silk fibroin extraction and dissolution process. (Redrawn from
[44])
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Silk Fibroin Extraction
The silk from the Bombyx Mori cocoon comprises of two key fibroin protein
chains, light (25 kDa) and heavy (325 kDa) chains [44]. These essential protein chains are
enclosed in sericin, a glue-like protein securing the fibroin chains together to form the
cocoon – a composite fiber structure that protects the growing worm. To effectively
process and extract the silk fibroin from the raw cocoons, the embedded sericin wax must
be removed.
A 2-liter glass beaker is filled with 2 liters of ultrapure water, covered with
aluminum foil and heated to a boil. Bombyx Mori cocoons are cut with scissors into dimesized pieces and the residual silkworm waste within the cocoons is disposed. A 0.02 M
solution of sodium carbonate (Na2CO3) is made by adding 4.24 grams of Na2CO3 to 2 L of
boiling water to completely dissolve into solution. Subsequently, 5 grams of cocoon pieces
is added to the boiling Na2CO3-water solution for 30 minutes and intermittently stirred with
a glass stir bar to promote silk fibroin dispersion. After 30 minutes, the silk fibroin is
promptly removed with a spatula and cooled under flowing ultrapure cold water. Excess
water is then pressed out of the silk, placed in a 1-liter glass beaker filled with ultrapure
water and soaked for 20 minutes. The rinse and soak procedure is repeated a total of three
times. After the third wash, the silk is pressed to remove residual water and spread out
onto a clean piece of aluminum foil and allowed to dry in a fume hood overnight. The 5
grams of cocoon pieces generates 3.3 grams of dry silk wool after the sericin wax has been
fully washed away.
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Fibroin Dissolution
The dried silk fibroin is added to a calcium nitrate tetrahydrate–methanol solution
(molar ratio 1:4:2 Ca:H2O:MeOH) at a 10% weight-to-volume concentration (mg/mL) in
a sealed container and placed in an oven at 65°C for 3 hours to fully dissolve with
intermittent stirring. The fully dissolved fibroin solution (approximately 32 mL) is placed
into a 22 mm diameter, 355 mm long dialysis tube with a molecular weight cut off of 7
kDa (Snakeskin #68700, Thermo Scientific, Rockford, IL) with 2 weighted clips on the
bottom of the tube and 3 floating clips on top of the tube, and all air is evacuated from the
tube. The clipped length of the dialysis tube is 305 mm.

The dissolved silk fibroin is

dialyzed against deionized water in a 2-liter graduated cylinder for 4 days, changing the
water every 24 hours. The dialyzed SF solution is stored at 4°C until use.

Chitosan Dissolution
High molecular weight chitosan (419419, Sigma-Aldrich Co., St. Louis, MO) is
dissolved at 3.66% (g/mL) in 2% acetic acid. Thoroughly mix the Chitosan blend for 15
minutes at approximately 2000 RPM using the custom material mixing system described
above in Section 3.1.2. The fully blended chitosan is then stored at 4°C until use.

Blending of Silk Fibroin with Chitosan
Three solutions of silk fibroin and chitosan are blended by volume and
characterized for this investigation (
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Table 3.6). The typical volume of the blended SFCS solution regardless of
concentration is 50 mL; therefore, known volumes of each material blend are utilized in
each experiment. The blended SFCS solution is thoroughly mixed using the custom
material mixing system for 15 minutes at approximately 2000 RPM.

Table 3.6. List of SFCS blends and corresponding volumes for 50 mL solution.
SFCS
Blend

% SF

% CS

SF (V) CS (V)
{mL}
{mL}

30:70

30

70

15

35

50:50

50

50

25

25

70:30

70

30

35

15

The blended solution is then equally divided (25 mL) and placed into two 22mm
diameter, 250 mm long – 7 kDa dialysis tubes with 1 weighted clip on the bottom of the
tube and 2 floating clips on the top of the tube, and all air is evacuated. The clipped length
is approximately 200 mm. The blended SFCS is dialyzed against deionized water in a 7.5liter tub for 3 days with the water being changed every 24 hours. Subsequently, the clear
and homogeneous aqueous solution is stored at 4°C until use.
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Blending of SFCS with Zinc Oxide Nanoparticles
ZnO nanoparticles (US Research Nanomaterials, Inc., Houston, TX) of 30 nm, 45
nm and 200 nm average particle size are selected as the active phase of the piezocomposite.
The ZnO nanoparticles for each respective size are ultrasonically dispersed in deionized
water at a concentration of 250 mg/mL. The final form of the piezocomposite tissue
scaffolds is prepared using the process described next.

Silk Fibroin - Chitosan - ZnO Blend Scaffold Preparation
The ZnO dispersions are combined with the SFCS blends to reach the desired
weight fractions (2%, 5% and 10%) of SFCS:ZnO composite using a drip method while
being stirred at 500 RPM on the custom material mixing system. The ZnO:SFCS blends
are injected into the laser cut acrylic molds described above via 5 mL pipetter and frozen
in a -80°C freezer overnight. The next day, the samples are lyophilized for 24 hours. The
dried samples are then removed from the molds and treated with 50:50 (v/v) MeOH:NaOH
(1N) solution for 15 min, to crystallize the silk content and neutralize the chitosan content.
The MeOH:NaOH solution is replaced with 1N NaOH solution and the samples are then
treated for 12 hours. The samples are promptly removed from the NaOH solution and
immediately placed in a 1X phosphate buffered saline solution at 37°C to leach out the
NaOH. The phosphate buffered saline solution is changed every 4 hours until the solution
pH has equilibrated to 7.4.
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Tissue Scaffold Porosity
Tissue scaffolds containing a 3D porous matrix provide mechanical stability to
support cell adhesion and expansion while allowing integration at a rate analogous with
new tissue growth. Porosity is also critical to provide sufficient opportunity for cell
migration, adhesion, and expansion while sustaining adequate transport for nutrient and
gas exchange [45] [46] [47]. The lyophilized SFCS tissue scaffolds typically have a high
porosity and interconnected pores. The addition of ZnO nanoparticles to the blended SFCS
may affect the porous nature of the scaffold; thus, porosity characterization must be
conducted.
The following procedure is performed to obtain the pore and apparent scaffold
volume. Next, the effective porosity of SFCS-ZnO samples is calculated by means of the
fluid re-saturation method [47].

Specifically, pore volume is calculated using the

relationship:

𝑉1 =

(𝑀𝑎 − 𝑀𝑏 ) − 𝑀0
𝜌

(21)

where M0 is the dry mass of the lyophilized SFCS samples. Ma is the mass of 2 mL of
100% ethanol (ρ = 789 kg/m³) dispensed into a glass weighing dish with the dry SFCS
samples fully immersed and saturated. The saturated SFCS sample is then removed and
the weighing dish is reweighed giving the mass Mb. The change in mass divided by the
density of the ethanol results in the pore volume.
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A 10 mL pycnometer (Figure 3.46) is filled with ethanol, weighed and recorded as
M1. The ethanol is poured out and the wet scaffold, previously soaked in ethanol within
the weighing dish, is placed in the pycnometer, and ethanol is added until the pycnometer
is once again properly filled. The pycnometer is reweighed with the added SFCS sample
and the mass denoted as M2. The apparent scaffold volume is then calculated using:

𝑉2 =

(𝑀𝑎 − 𝑀𝑏 ) − (𝑀2 − 𝑀1 )
ρ

(22)

The effective porosity of the SFCS samples is calculated according to the following
equation:

𝑉1
𝑀𝑎 − 𝑀𝑏 − 𝑀0
𝜀 = ( ) ×100% = (
) ×100%
(𝑀𝑎 − 𝑀𝑏 ) − (𝑀2 − 𝑀1 )
𝑉2

where porosity is the ratio of the pore volume (V1) to effective scaffold volume (V2).
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(23)

Figure 3.46. Image of 10 mL pycnometer.

Tissue Scaffold Water Absorption
A critical aspect of an engineered tissue scaffold is the capability of storing water,
an essential characteristic for the support of a multitude of cellular functions by allowing
ease of diffusion for cell nutrients and waste [37] [40] [48].

Thus, water absorption

experiments are conducted on the SFCS scaffolds. The scaffolds are again freeze dried via
lyophilization and weighed (Wdry). The samples are placed in saline and then placed in a
heated water bath at 37°C. The samples are removed from the bath at prescribed time
intervals of 30, 60, 90, 120, 180, and 240 minutes and the mass is recorded. Before the
mass measurements are recorded, the SFCS samples are blotted to remove any excess
water. Water absorption is calculated according to the following equation:
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𝑊𝐴% =

𝑊𝑤𝑒𝑡 − 𝑊𝑑𝑟𝑦
×100
𝑊𝑑𝑟𝑦

(24)

where Wdry is the dry mass of the lyophilized SFCS samples and Wwet is the final measured
mass of the wet sample after soaking in saline for 240 minutes.

Mechanical characterization of biocompatible piezo-composites
Dimensional Characteristics
SFCS-ZnO blends are mixed and then injected into the ring-shaped molds. A
pipette is employed to dispense 1.5 mL of the SFCS-ZnO blend into each mold cavity.
After curing, the SFCS-ZnO blends are removed from the mold and washed in
MeOH/NaOH solutions. Finally, the blends are stored in 1X PBS and the outer diameter
(OD), wall thickness (WT), and height (H) of the ring samples are measured with a pair of
digital calipers and recorded. These dimensions alongside the measured porosity of each
blend are used to determine the actual cross sectional area of each sample blend.

Mechanical characteristics
Uniaxial Tensile Testing
Mechanical and viscoelastic characteristics for all the SFCS-ZnO blends are
evaluated in this study. Uniaxial tensile, stress relaxation and creep tests are performed
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using the ring-shaped samples. The selected geometry of the ring-shaped samples
alleviated any experimental error due to localized failure via inappropriate clamping of the
specimens as seen with the traditional dog-bone type tensile specimens. Slippage and
unwanted premature failure near the clamp grips are also common modes of failure and
stress measurement uncertainty [49]. Specimen failure is defined as a complete breakage
of the ring sample. Several metrics are extracted from the uniaxial tensile test data such as
modulus of elasticity, ultimate strength, yield strength, and elongation at break. The
modulus of elasticity of the material is defined as the slope of the linear portion of the
stress-strain curve, is illustrated as the triangle in Figure 3.47 and is also represented as:

𝐸=

∆𝜎
∆𝜀

(25)

The gray hatched areas also represent the linear region of the stress-strain curve. The
ultimate strength is represented as the maximum stress prior to failure of the specimen (Red
X in Figure 3.47). The yield point or yield strength (Green + in Figure 3.47) is defined as
the point at which the linear region began to change by at least 10% [49]. The SFCS-ZnO
ring samples are subjected to tensile testing on the Admet Uniaxial Microtester 4000
describe above. The constructs are mounted between two custom fabricated hooks adapted
to securely mount to the mechanical tester, as shown in Figure 3.48.
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Figure 3.47. Graph representing a typical stress-strain relations of a SFCS-ZnO
specimen, in which the modulus, yield stress, ultimate stress, and elongation at break are
defined.

Figure 3.48. 3D rendering of custom “hook type” fixture to effectively grip the
fabricated ring devices.
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The center-to-center distance of the hook type fixture is set as the gauge length of the
samples. The rings are loaded at a displacement rate of 50 mm/min and preconditioned
with 10 cyclic loading sequences and a displacement estimated at 25% of failure strain
before performing the tensile test to failure, as shown in the programmed testing sequence
in Figure 3.49. Ultimate tensile strength (σUTS) and elongation at break (εB) are defined by
the peak stress experienced by the sample and maximum strain at failure by the samples,
respectively. Engineering stresses are calculated by dividing the recorded loads by the
cross-sectional area of the SFCS-ZnO sample using the initial measured construct
dimensions, while also compensating for material porosity. Engineering strain is used to
measure the deformation of the vascular constructs. Stress-strain curves are plotted and
analyzed using a Microsoft Excel script to calculate the tensile parameters.

Figure 3.49. Inset of Testing Procedure from the Admet MTESTQuattro software.
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Viscoelastic characteristics
Biomaterials, such as tissue scaffolds, in particular the SFCS-ZnO composite, have
a time dependent or viscoelastic behavior. This time dependence is due to the distinct
molecular structure of polymeric materials [50] [51] [52].

Stress Relaxation
One essential technique for characterizing the viscoelastic time dependent behavior
of a material is a stress relaxation test. With this test, a constant strain is suddenly applied
to a sample, being rapidly stretched at 50 mm/min to the new strained position and held for
a prescribed time period (Figure 3.50 (left)). The Relaxation Modulus is given by:

𝐸(𝑡) =

𝜎(𝑡)
𝜀0

(26)

where σ(t) is the stress and ε0 is the constant strain value. The stress is calculated from the
recorded force value that is needed to maintain the constant strain input, which decreases
with time (Figure 3.50 (right)). Since stress is a function of time, the Relaxation Modulus
at a constant strain will also vary with time. Equation () demonstrates the uniaxial stressstrain relation for a viscoelastic material that is analogous to Hooke’s Law for a case of a
constant strain input.
The Initial Modulus at a time of t = 0 seconds is given by:
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𝐸(𝑡 = 0) =

𝜎(𝑡 = 0)
= 𝐸0
𝜀0

(27)

where σ0 is the peak stress experienced by the sample upon application of constant strain.
Similarly, the Equilibrium Modulus at a time of t = ∞ is given by:

𝐸(𝑡 = ∞) =

𝜎(𝑡 = ∞)
= 𝐸∞
𝜀0

(28)

where σ∞ is the relaxed stress experienced by the sample after of constant strain.

Figure 3.50. Illustration of Relaxation Test: Constant strain input (left) and
representative stress output (right).

Stress-relaxation testing of the different SFCS-ZnO constructs is performed as
described by others [53]. Like the uniaxial tensile testing, the SFCS-ZnO ring samples are
molded, processed and then mounted between the two adapted hooks of the hook type
fixture which is placed in the previously stated mechanical tester. These tests require an
extended timeframe; therefore, a heated bath is utilized to maintain the ring samples at a
constant temperature (37°C) in saline during the entire programmed test. The ring samples
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are loaded at a displacement rate of 50 mm/min until an initial displacement value of 3.00
mm is reached and held at this displacement value for 240 seconds. Then, the ring samples
are subjected to five rapid incremental displacement steps of 0.5 mm and held for a period
of 120 seconds for each incremental step to allow the SFCS-ZnO sample to reach
equilibrium. Initial modulus, denoted as the maximum stress value recorded for each
relaxation cycle. Whereas, the equilibrium modulus, denoted as the minimum stress
recorded at the end of each relaxation cycle. Stress-relaxation data are plotted and analyzed
using a custom Microsoft Excel script, allowing for the detection of peak and equilibrium
values as well as calculation of the initial and equilibrium moduli.

Creep
An additional method for characterizing the viscoelastic time dependent behavior
of a material is using a creep test. A sudden stress is applied to the sample at a rate 50
mm/min and maintained to a constant value. Strain under constant load increases with time
and the below mentioned test defines a quantity called Creep Compliance that is given by:

𝐷(𝑡) =

𝜀(𝑡)
𝜎0

(29)

where ε(t) is time dependent strain and σ0 is the applied constant stress value. Strain is
calculated from the recorded displacement necessary to maintain the constant stress input,
which increases with time (Figure 3.51 (top)). Point 1 in the bottom of Figure 3.51
represents the end of the linear elastic strain region of the sample during sudden loading
and the start of the viscoelastic creep region at a specific constant stress. Point 2 represents
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the end of the creep region for the specified 720 second creep test duration and the start of
the sudden return to the sample zero stress state. Point 3 represents the end of the sudden
reduction of elastic strain induced by returning the material to a zero stress state as seen in
the upper stress plot and the start of the creep recovery where the material attempts to return
to the unloaded recovered position. Point 4 represents the end of the creep recovery region
for the specified 720 second creep recovery test duration, if this point is above a zero-strain
state then a residual strain has been induced via the creep test.

Figure 3.51. Illustration of Creep Test: Constant stress input (top) and representative
strain output (bottom).

Linear Viscoelastic Behavior via Isochronous Stress-Strain Relationship
One method to determine linearity is by conducting creep tests at different stress
levels and obtaining the creep compliance at constant times as well as generating the
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“isochronous” stress-strain diagram. If this isochronous variation of the stress versus strain
plot is linear at any recorded time, then the material demonstrates linear tendencies (Figure
3.52). If the variation in the plot is nonlinear, the material demonstrates nonlinear
viscoelastic tendencies. Linearity of the isochronous stress – strain plot derives from the
fact that the ratio of the strain to stress at a given time, ti, from each stress level must be
identical if the material is to be linear. That is, for t1 we have

𝐷(𝑡 = 𝑡1 ) =

𝜀𝑎 (𝑡=𝑡1 )
𝜎0 │𝑎

=

𝜀𝑏 (𝑡=𝑡1 )
𝜎0 │𝑏

=

𝜀𝑐 (𝑡=𝑡1 )
𝜎0 │𝑐

(30)

which means that the compliance D(t = t1) is independent of stress level.
Similarly

𝐷(𝑡 = 𝑡2 ) =

𝜀𝑎 (𝑡=𝑡2 )

𝐷(𝑡 = 𝑡3 ) =

𝜀𝑎 (𝑡=𝑡3 )

𝜎0 │𝑎

=

𝜀𝑏 (𝑡=𝑡2 )
𝜎0 │𝑏

=

𝜀𝑐 (𝑡=𝑡2 )

=

𝜀𝑐 (𝑡=𝑡3 )

𝜎0 │𝑐

(31)

and

𝜎0 │𝑎

=

𝜀𝑏 (𝑡=𝑡3 )
𝜎0 │𝑏

𝜎0 │𝑐

(32)

The conditions above can be deduced from the requirement that the creep compliance is
only a function of time (D(t)), and not a function of stress level (D(t,σ)), for a linear
material.
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Figure 3.52. Linearity illustrated by an isochronous stress-strain plot at constant times
from creep tests [50].

Creep testing of the different SFCS-ZnO constructs is performed as described by
others [53]. Similar to the uniaxial tensile and stress relaxation testing, the SFCS-ZnO ring
samples are molded, processed and then mounted between the two adapted hook type
fixtures which is placed in previously stated mechanical tester. These tests also require an
extended timeframe; therefore, a heated bath is utilized to maintain the ring samples at a
constant temperature (37°C) in saline during the entire programmed test. The rings are
loaded at a displacement rate of 50 mm/min until the initial creep force value of 5.00 grams
is reached and then held within ±1% of the nominal force value for 720 seconds. The force
is then returned to near 0 grams for another 720 seconds allowing the material to recover.
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This 1440 second cycle is followed by 2 additional creep and creep recovery cycles in
incremental force steps of 2.5 grams for each additional step to allow the SFCS-ZnO
sample to reach equilibrium. The creep data is plotted and analyzed using a custom
Microsoft Excel script, allowing the manual detection of points for the elastic strain (1),
creep strain (2), elastic recovery (3), creep recovery (4), and residual strain (5) values.

Compliance and Circumferential Strain Testing
The compliance and circumferential strain of the engineered tube and actual porcine
aortic tissue was determined using the imaging rig shown in Figure 3.53. The vessel was
mounted in the custom distension unit and filled with saline. A wireless 1080P camera
(Hero 3+ Silver Edition, GoPro, Inc., San Mateo, CA) with attached microscope LED array
ring light (LED-144A, Amscope, Irvine, CA) was employed to capture images of the
distended state of the mounted vessel at internal pressures ranging from 70 mmHg up to
140 mmHg.
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Figure 3.53. Image of the camera setup for capturing vessel diameters at varying static
pressures.

The captured images were imported into an image processing and analysis software
(ImageJ, National Institutes of Health, Bethesda, MD) and the outer diameter was
measured. Figure 3.54(a.) – f.)) Figure 3.55 (a.) – f.)) demonstrate static vessel distension
of the engineered elastomeric tube and descending porcine aorta, respectively. The applied
internal pressures ranged from 70 mmHg to 140 mmHg.
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a.)

b.)

c.)

d.)

e.)

f.)
Figure 3.54. Series of images taken at internal vessel pressures at a.) 70mmHg, b.) 80
mmHg c.) 90 mmHg, d.) 100 mmHg, e.) 120 mmHg, and f.) 140 mmHg
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a.)

b.)

c.)

d.)

e.)

f.)
Figure 3.55. Series of images taken at internal vessel pressures at a.) 70 mmHg, b.) 80
mmHg, c.) 90 mmHg, d.) 100 mmHg, e.) 120mmHg, and f.) 140mmHg
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Electrical characterization of Biocompatible Piezo-Composites
Electrical characteristics for select SFCS-ZnO blends are evaluated in this study.
Electrical response to shear stress and vessel distension are performed by means of the disc
shaped (cookie) and ring-shaped (donut) samples, respectively.

Shear Testing
Shear testing is performed on all SFCS-ZnO blends by employing the custom shear
testing apparatus as described in Section 3.2.1. The 2-mm thick SFCS-ZnO disk sample is
mounted between the fixed and movable electrode plates (as shown in Figure 3.56). A
series of programmed displacements are applied to the disk samples.

Figure 3.56. Image of shear testing fixture with sample loaded and prepared for the test.

99

The programmed displacements and the calculated real shear strain are shown in Table 3.7.
Permutations of the stated strain cycles were input thru a control and data acquisition
software package (LabView, National Instruments Corp., Austin, TX) at three prescribed
frequencies, 0.6, 1.2 and 2.4 Hz. Table 3.8 represents the total number of strain/frequency
permutations applied the samples during the shear tests. The measured shaker displacement
and SFCS-ZnO sample electrical response is recorded for each experiment.

Table 3.7. Applied shear strain to samples
Shaker Displacement
(μm)

Shear
Strain

100

5.0%

200

10.0%

500

25.0%

Table 3.8. Permutations of programmed strains and frequencies applied during typical
electrical test.

Strain Amplitude (%)
Frequency (Hz)

Set 1

Set 2

Set 3

5

10

25

0.6 1.2 2.4 0.6 1.2 2.4 0.6 1.2 2.4
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The primary purpose of these sets of experiments was to identify which blends
generate the highest response to an applied strain to reduce the number of blends
investigated in the distension testing trials. The results will assist the investigator in
narrowing the field of test samples to up to four independent blends that generate
significantly higher response than others. The four blend candidates with the highest
electrical response will then be advanced into the vessel distension investigation for further
study.

Vessel Distension Testing
Vessel distension testing is performed on select SFCS-ZnO blends by employing
the EVDSA as described in Section 3.2.2. The SFCS-ZnO ring sample is mounted onto
the vessel as shown in Figure 3.57 by sliding the sample over the cut ends prior to
placement in EVDSA.

Table 3.9 represents the total number of pressure/frequency

permutations applied to the samples during the distension tests. The measured shaker
displacement, internal vessel pressure, and SFCS-ZnO sample electrical response is
recorded for each experiment.
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Figure 3.57. Image of mounted ring sample on aorta.

Table 3.9. Permutations of pressures and frequencies applied during typical vessel
distension test.

Strain Amplitude (%)
Frequency (Hz)

Set 1

Set 2

Set 3

100/70

120/70

140/70

0.6 1.2 2.4 0.6 1.2 2.4 0.6 1.2 2.4

Determination of Electrode Placement for Vessel Distension Study
Placement of the wire electrodes may affect electrical response of the SFCS-ZnO
sample .

Determining the optimal electrode location is investigated via testing six

configurations. Three positions with the electrode wires are aligned in the axial direction,
with respect to the centerline of the distended vessel, at 45˚, 90˚, and 180˚ between them
(Figure 3.58 a.), c.), and e.), respectively). While the other three positions are aligned to
the radial direction, also at 45˚, 90˚, and 180˚ between them (Figure 3.58 b.), d.), and f.),
respectively). The electrode placement investigation is performed on a single SFCS-ZnO
blend, one of the four selected with significantly higher response from the shear testing
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investigation. The noted electrodes are 26G tinned copper wire (0.405 mm in diameter)
with insulation. The wires terminate directly into the inputs channels of the differential
amplifier described in Section 3.2.5. Figure 3.59 demonstrates the actual placement of the
electrode wires in an SFCS-ZnO ring sample.
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a.)

b.)

c.)

d.)

e.)

f.)

Figure 3.58. CAD rendering illustrating location of wire electrodes placed at 45˚ (a. and
b.), 90˚ (c. and d.), and 180˚ (e. and f.) oriented in both axial and radial configurations
with respect to the vessel geometry.
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a.)

b.)

c.)

d.)

e.)

f.)

Figure 3.59. Images of actual electrode placement at 45˚, 90˚, and 180˚ oriented in both
axial and radial configurations with respect to the vessel geometry.
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Figure 3.60 demonstrates the typical placement of the tested samples with attached
electrodes on the excised descending aorta.

Figure 3.60. Image of SFCS-ZnO ring sample mounted onto an excised descending aorta
with electrode mounted in 180˚ axial orientation.

Summary
The sections in this chapter have outlined the details taken to fabricate tissue
scaffolds comprised of silk fibroin, chitosan, and zinc oxide nanoparticles. Metrics such
as porosity and water absorption are measured for scaffold performance to take up water
and potentially nourish surrounding tissue upon potential implantation. Mechanical and
viscoelastic characteristics are established via uniaxial tensile, stress relaxation and creep
testing, respectively. Electrical response of the SFCS-ZnO samples is experienced and
recorded from mechanical shear strain and circumferential strain via vessel distension. The
development of the blending techniques to the testing of a proof of concept perivascular
band for measuring arterial distension will be discussed.
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CHAPTER 4:

RESULTS AND DISCUSSION

In this chapter, the results associated with the specific aims outlined in the
introduction chapter will be examined. The results of the biocompatible piezo composite
formulation will be presented and metric data analyzed. The mechanical and viscoelastic
properties of the composite materials will then be presented and evaluated.

The

piezoelectric properties of the composite scaffold are then presented. Finally, the electrical
response of the piezo-composite will be analyzed while experiencing circumferential strain
via distension of an engineered blood vessel and one extracted from an animal.

Formulation of Biocompatible Piezo-Composites
SFCS-ZnO Blend Viscometry
The shear viscosity of the SFCS-ZnO blends was measured prior to the
lyophilization step of the scaffold fabrication process using the cone-and-plate viscometer
described in Section 3.1.3. However, prior to measuring the shear viscosities of three
SFCS-ZnO blends, the shear viscosities of the SFCS scaffolds at the three blended
concentrations (30:70; 50:50 & 70:30) without ZnO nanoparticles were determined (Figure
4.1). Non-Newtonian thixotropic or shear thinning behavior was observed with each SFCS
blend, demonstrating a reduction in shear viscosity as the shear strain increased. The nonNewtonian shear thinning behavior was anticipated since both SF and CS natively
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demonstrate this phenomenon, due to the alignment of molecules and resistance to friction
between adjacent fibers within the blend as the shear rate is increased [54].

Figure 4.1. Viscosity Measurements of SFCS composites absent of ZnO nanoparticles

Subsequently, shear viscosity of the SFCS scaffolds with ZnO nanoparticles were
measured for each ZnO nanoparticle size (30 nm, 45 nm & 200 nm) at the three different
nanoparticle concentrations (2%, 5% & 10% nanoparticles by vol.) While viscosity
measurement experiments were conducted on all the blends, many of the blends were
unable to yield reliable or accurate values due to torque overload on the cone and plate
viscometer caused by shear-induced coagulation of the nanoparticles (Table 4.1). Shearinduced coagulation has been reported to occur when particle-to-particle interaction
increases with smaller particle size at constant weight fractions [55] [36]. This behavior
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was observed in the SFCS-ZnO blends listed in (Table 4.1), so these blends were unable to
yield accurate shear values and were eliminated from further investigation.

Table 4.1. List of blends that yielded accurate (successful blends) and inaccurate
(unsuccessful blends) viscosities..

Unsuccessful Blends

Successful Blends

3070-30nm-10%

3070-30nm-2%

3070-45nm-10%

3070-30nm-5%

5050-30nm-10%

3070-45nm-2%

5050-45nm-5%

3070-45nm-5%

5050-45nm-10%

3070-200nm-2%

5050-200nm-5%

3070-200nm-5%

7030-30nm-2%

3070-200nm-10%

7030-30nm-5%

5050-30nm-2%

7030-45nm-2%

5050-30nm-5%

7030-45nm-5%

5050-30nm-10%

7030-200nm-2%

5050-45nm-2%

7030-200nm-5%

5050-45nm-5%
5050-200nm-2%

109

Figure 4.2. Image of shear induced coagulation of ZnO nanoparticles in SFCS composite
for a 2 mL SFCS-ZnO sample after exposed to shear via the cone and plate viscometer.
Particle coagulation was clearly present. (Additional images of unsuccessful blends are
shown in Appendix 2.)

Just as observed with the SFCS only blends, non-Newtonian shear thinning was
seen with each SFCS-ZnO blend with the viscosity decreasing as the strain rate increased
(Figure 4.3). This plot displays the 30:70 blends with 200 nm ZnO particles at all three
weight fractions (WF) and represents a typical trend for all blends. It is evident that the
shear viscosity increases with WF.
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Figure 4.3. Plot of Viscosity vs. Shear Rate for 30:70 SFCS blends with 200 nm particles
at varying concentrations.

pH Measurement of Composite Blends
The pH of each SFCS-ZnO scaffold blend was measured using the Beckman
Coulter pH and Electrochemistry Meter. The pH of the SFCS blends only (no ZnO
nanoparticles) displayed a near neutral pH of approximately 6.5 with no significant
difference in pH between each blend type (Table 4.2). While for the aqueous ZnO solutions
(0.25 g/mL concentration), the pH was found to be of high alkalinity of approximately 9.5
(Figure 4.4) and there was a significant difference in pH between the 30 nm and 45 nm (ρ*
= 0.003) and 30 nm and 200 nm (ρ** = 0.016) solutions, while the pH values were
insignificant between the 45 nm and 200 nm (ρ = 0.098).

111

Table 4.2. pH of SFCS composites without embedded ZnO nanoparticles
Blend

Average pH

Standard Deviation

30:70

6.49

0.04

50:50

6.44

0.05

70:30

6.46

0.08

Figure 4.4. Bar chart of pH of aqueous dispersion ZnO nanoparticle.
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The pH of each of the SFCS-ZnO blends were measured and an increase in pH was
observed for the individual blends of SFCS-ZnO from 2% up to 10% (Figure 4.5), albeit
not significant.

An analysis of variance (ANOVA) was performed to determine

significance of individual factors, SFCS Blend (30:70, 50:50, 70:30), ZnO Particle Size
(30 nm, 45 nm, 200 nm), and ZnO weight percent (2%, 5%, 10%). Some significant
differences were found for pH values between specific blend combinations; however, no
general significant trend was seen.
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Figure 4.5. Bar chart illustrating average pH of SFCS-ZnO blends with standard
deviation.
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Water Absorption
As described in chapter 3, the total mass of the engineered SFCS-ZnO blended
scaffolds soaked in water were recorded at prescribed time intervals (0 (dry), 30, 60, 90,
120, 180, and 240 minutes). The average change in the dry mass versus wet mass for each
of the pure SFCS blends were plotted (Figure 4.6). At the 240-minute interval, the 30:70,
50:50, and 70:30 blends were all significantly different. It was noted that increasing
amounts of chitosan resulted in significantly higher mass due to chitosan’s ability to “take
up” water more efficiently [37]. The average change in mass for each of the SFCS-ZnO
blends was also found to significantly increase as the concentration of zinc oxide
nanoparticles increased (Figure 4.7, Figure 4.8, Figure 4.9).

Figure 4.6. Mass properties of pure SFCS blended scaffolds.
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Figure 4.7. Average change in mass for each of the SFCS-ZnO blends with 30 nm
particles. Note: The 70:30, 30 nm, 10% by weight is not shown due to inability to mix
the particular blend.
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Figure 4.8. Average change in mass for each of the SFCS-ZnO blends with 45 nm
particles. Note: The 70:30, 45 nm, 10% by weight is not shown due to inability to mix
the particular blend.
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Figure 4.9. Average change in mass for each of the SFCS-ZnO blends with 200 nm
particles. Note: The 70:30, 200 nm, 10% by weight is not shown due to inability to mix
the particular blend.
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Water absorption was calculated to delineate the effects of an increase in mass due
to the addition of zinc oxide and the scaffold’s natural capability for absorbing water. The
capacity of each SFCS-ZnO blend to absorb water was calculated via Equation (33) and
plotted at 30, 60, 90, 120, 180, and 240 minute intervals (Figure 4.10). Measurements were
concluded at the 240-minute interval due to all samples reaching steady state with an
average percent change, %∆, of:

%∆ =

𝐴240 − 𝐴180
×100%
𝐴180

(33)

where A240 and A180 were the measured water absorption values at the corresponding time
intervals. The average percent change among all datasets of the SFCS only blends was
2.45%, therefore water absorption was determined to reach steady state. The water
adsorption data for the SFCS only blends was found to follow the same trend as Figure 4.7,
Figure 4.8, Figure 4.9, where the scaffolds with higher chitosan content also exhibited a
higher affinity for water absorption.
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Figure 4.10. Water absorption of pure SFCS blended scaffolds up to a time interval of 4
hours.

Similarly, the capacity of each SFCS-ZnO blend to absorb water was calculated
and plotted at 30, 60, 90, 120, 180, and 240 minute intervals (Figure 4.11, Figure 4.12,
Figure 4.13). The data demonstrated that a higher ZnO content for any particular SFCS
blend reduced the capacity of the scaffold to absorb water. Furthermore, as the ZnO weight
concentration increased, the blended sample’s ability to absorb water significantly
decreased (Figure 4.14). This phenomenon was due to ZnO having a natural
hydrophobicity [56] [57], which counteracted the hydrophilicity and natural ability of pure
SFCS blends to take up water at higher concentrations, in addition to the nanoparticles
physically occupying the spaces in the scaffold pores or matrix where the water would
potentially reside.
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Figure 4.11. Average water absorption data for SFCS-ZnO blends with 30 nm particles
representing collection intervals up to 240 minutes. Note: The 70:30, 30 nm, 10% by
weight is not shown due to inability to mix the particular blend.
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Figure 4.12. Average water absorption data for SFCS-ZnO blends with 45 nm particles
representing collection intervals up to 240 minutes. Note: The 70:30, 45 nm, 10% by
weight is not shown due to inability to mix the particular blend.
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Figure 4.13. Average water absorption data for SFCS-ZnO blends with 200 nm particles
representing collection intervals up to 240 minutes. Note: The 70:30, 200 nm, 10% by
weight is not shown due to inability to mix the particular blend.
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Figure 4.14. Bar chart illustrating differences water absorption between SFCS-ZnO
blends.

Scaffold Metrology
Basic metrology was performed on the SFCS-ZnO ring specimens after being
processed through the post lyophilization crystallization and neutralization process with
MeOH:NaOH as described in Section 3.3.1.

Three samples from each blend were

extracted from the PBS storage solution and the outer diameter (ɸ), wall thickness (WT)
and the height of the ring (H) were recorded using a set of 6-inch digital calipers.
The dimensional data was analyzed to determine whether SFCS blend, ZnO particle
size, or ZnO concentration affected the overall dimensions of the fabricated rings within
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the mold due to material shrinkage during the lyophilization, crystallization and
neutralization processes. The SFCS blend was found to significantly affect (p < 0.05) the
outer diameter, wall thickness, and height values of the SFCS-ZnO rings (Table 4.3). On
the other hand, the particle size was found to have no significant effect (p > 0.05) on the
outer diameter, wall thickness, and height of the SFCS-ZnO ring assemblies shown in
Table 4.4. Similar to the SFCS blend, the ZnO concentration was found to significantly
effect (p < 0.05) the outer diameter, wall thickness, and height values of the SFCS-ZnO
rings shown in Table 4.5.
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Table 4.3. Average outer diameter (Ø), wall thickness (WT), and height (H) of each
SFCS-ZnO blend with respect to SFCS Blend.

SFCS
BLEND

Ø (mm)

WT (mm)

H (mm)

Average ± Std.
Dev.

Average ± Std.
Dev.

Average ± Std.
Dev.

3070

16.179

± 0.704

3.436

±

0.117

7.679

±

0.498

5050

15.820

± 0.262

3.400

±

0.090

7.430

±

0.425

7030

15.741

± 0.536

3.186

±

0.150

7.299

±

0.541

Table 4.4. Average outer diameter (Ø), wall thickness (WT), and height (H) of each
SFCS-ZnO blend with respect to Particle Size (nm).

PARTICLE
SIZE (nm)

Ø (mm)

WT (mm)

H (mm)

Average ± Std.
Dev.

Average ± Std.
Dev.

Average ± Std.
Dev.

30

15.995

± 0.471

3.298

±

0.124

7.459

±

0.402

45

16.035

± 0.491

3.357

±

0.199

7.351

±

0.630

200

15.773

± 0.683

3.425

±

0.111

7.662

±

0.405
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Table 4.5. Average outer diameter (Ø), wall thickness (WT), and height (H) of each
SFCS-ZnO blend with respect to ZnO Concentration.

ZnO
CONC.

Ø (mm)

WT (mm)

H (mm)

Average ± Std.
Dev.

Average ± Std.
Dev.

Average ± Std.
Dev.

2%

15.458

± 0.394

3.311

±

0.141

7.157

±

0.403

5%

16.100

± 0.261

3.367

±

0.191

7.503

±

0.435

10%

16.402

± 0.536

3.422

±

0.089

7.973

±

0.222

After the MeOH/NaOH crystallization and neutralization wash, the measured
SFCS-ZnO scaffolds had a global average shrinkage value of 20.8% ± 1.9% for all 3 critical
dimensions with respect the mold dimensions. The methanol treatment of the SFCS-ZnO
specimens induces the transition of random coil conformation to β-sheet structure of the
silk fibroin which results in the shrinkage of materials [58]. Surface tension of the SFCS
material itself contributed to the compacting of the overall porous structure, which resulted
in the dimensional changes between the mold and final ring scaffolds. Gobin et al. [37]
also observed shrinkage, with up to a 75% dimensional change. The design of a mold
affects the scaffold architecture and the amount of shrinkage that the sample experiences;
this is a common occurrence among any engineered part that is injection molded.
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Imaging
Metrology was performed on the SFCS-ZnO blended specimens via the LEO Supra
35 VPSEM. Images of the ZnO nanoparticles that were employed within the blended
scaffolds were also recorded, shown in Figure 4.15. A droplet (50 µL) of each aqueous
ZnO solution (50 uL of 0.25 g/mL into 10 mL water) was dispensed onto a separate glass
slide via a micropipettor and allowed to dry. The dried sample was then placed within the
SEM for imaging.

a.)

c.)

b.)

Figure 4.15. SEM image of a.) 30nm ZnO nanoparticle, b.) 45nm ZnO nanoparticle, and
c.) 200nm ZnO nanoparticle

The scaffold cross-sectional morphology was imaged via scanning electron microscopy
after crystallization, neutralization and a secondary lyophilization process to ensure the
samples were dry for imaging. Large β-sheets were observed in near parallel formation,
for each blend of the pure SFCS (Figure 4.16, Figure 4.17, Figure 4.18). The addition of
ZnO nanoparticles did not affect the β-sheet formation in any of the blends for any of the
ZnO WT% (Figure 4.19, Figure 4.20, Figure 4.21). Also, as the WT% increased, the
nanoparticles were clearly visualized on the β-sheets. All other SEM images of SFCSZnO blends displaying nanoparticles can be found in Appendix 3.
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Figure 4.16. SEM images of pure 3070 SFCS tissue scaffold

Figure 4.17. SEM images of pure 5050 SFCS tissue scaffold

Figure 4.18. SEM images of pure 7030 SFCS tissue scaffold
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Figure 4.19. Low and high magnification SEM image of a cross section of 30:70 – 45nm
– 2% SFCS-ZnO tissue scaffold.

Figure 4.20. Low and high magnification SEM image of a cross section of 30:70 – 45nm
– 5% SFCS-ZnO tissue scaffold.

Figure 4.21. Low and high magnification SEM image of a cross section of 30:70 – 45nm
– 10% SFCS-ZnO tissue scaffold.
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Porosity Measurement
The resaturation technique was implemented to determine the porosity of each of
the SFCS-ZnO blends and the blends were processed through the protocol stated in Section
3.3.2. The pure SFCS blends had an average porosity of 92% ± 1.3%, 93% ± 1.2%, and
91% ± 4.4% for the 30:70, 50:50, and 70:30 SFCS blends, respectively, with no
significance difference between blend ratios (Figure 4.22). These highly porous blends
corresponded well with the constructs produced by Zeng et. al [47] and She et. al [46], both
reported an ~95% porosity for SFCS blends of similar ratios, employing the resaturation
method and mercury intrusion porosimetry methods, respectively. However, with the
addition of the ZnO nanoparticles, the average porosity decreased significantly (p < 0.05)
with respect to the pure SFCS blends (Figure 4.22).

Additionally, inconsistencies were

noted in the porosities of the SFCS-ZnO blends, which ranged from 24%±3.8% up to
78%±7.0%.

Thus, while the blends with ZnO nanoparticles showed a decrease in the

porosity as the concentration of nanoparticles increased; however, these trends were not
significantly different (p > 0.05). The decrease in the porosity was most likely to the ZnO
nanoparticles filling the voids in the SFCS scaffold matrices; thereby, decreasing the
porous nature of the scaffold.

Although the resaturation technique produced effective

porosities for each SFCS-ZnO blends, complete specimen saturation was difficult to
achieve. As a result, the porosities obtained in this study were probably lower than those
determined by other methods such as mercury intrusion porosimetry [59]. The latter
porosity measurement technique was not pursued for this investigation due to the lack
access to the equipment necessary to perform these measurements at or near the university.
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Figure 4.22. Bar chart exhibiting average porosity of all individual SFCS-ZnO blends

Mechanical Characterization of Biocompatible Piezo-Composites
Mechanical and viscoelastic properties of the SFCS-ZnO blends were evaluated
and analyzed. Uniaxial tensile, stress relaxation and creep tests were performed on the
SFCS-ZnO blends all at 37°C. The ring shaped specimens were placed in the 37°C water
bath and allowed to acclimate for 5 minutes before being mounted in the custom ring
testing fixture shown in Figure 4.23 before commencing with the testing procedure.
total of 3 rings per SFCS-ZnO blend group were tested.
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A

Figure 4.23. Image of SFCS-ZnO sample mounted in custom ring testing fixture

Uniaxial Tensile Testing
The tensile properties of the SFCS-ZnO blended scaffolds were determined via
uniaxial tensile testing while the samples were submersed in the water bath. Prior to
testing, each tensile sample was preconditioned, by completing 10 loading-unloading
cycles at a constant strain rate of 50 mm/min, to minimize the viscoelastic effects of the
material during the material characterization process and obtain consistent, repeatable
stress-strain curves. Thereafter, uniaxial tensile testing was performed on the samples using
a continuous sampling rate of 100 Hz for collecting the tensile force data and a crosshead
position at the strain rate of 50 mm/min Figure 29 shows a typical stress-strain plot of the
preconditioning process for an SFCS-ZnO specimen (30:70 – 30 nm – 2%) during the 10
applied loading cycles. The hysteresis loop shifts during the cyclic loading and eventually
converges to a deformed state with lower hysteresis. Figure 4.24 displays the loadingunloading hysteresis cycle in a stress-time plot that demonstrates that the measured stress
converges within 10 preconditioning cycles.
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Figure 4.24. (Top) Stress – Strain and (Bottom) Stress – Time plot demonstrating sample
preconditioning up to 50% strain in a typical SFCS-ZnO blend (30:70 – 30 nm – 2%)

The data collected from the acquisition system of the Admet Microtester were used
in conjunction with the cross sectional dimensions and individual porosity data to calculate
the stress of each specimen. These values were combined with the strain data and plotted
to produce the stress-strain curves similar to those shown in Figure 4.25.

Figure 4.26,

Figure 4.27, and Figure 4.28 display the stress – strain relationship for a single sample of
each SFCS-ZnO blend.
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Figure 4.25. Stress versus strain plot for three 70:30 – 45 nm – 5% SFCS-ZnO samples.

Figure 4.26. Stress versus strain plot for one sample of each ZnO composition in 30:70
blend.
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Figure 4.27. Stress versus strain plot for one sample of each ZnO composition in 50:50
blend

Figure 4.28. Stress versus strain plot for one sample of each ZnO composition in 70:30
blend
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The ultimate tensile strength (σULT), modulus of elasticity (E), and percent
elongation were determined from the acquired data.

Ultimate tensile strength was

measured as the maximum stress that the specimen can endure while elongated prior to
fracture. Figure 4.29 represents the average ultimate tensile strength of each individual
SFCS-ZnO blend, where the data shows a trend of a reduction in tensile strength with the
increase in ZnO nanoparticle concentration. Figure 4.30 demonstrates that the pure SFCS
blends exhibited significantly higher tensile strength (p*,** < 0.05) in comparison to the 5%
and 10 % SFCS-ZnO blends. The 2% and 5% SFCS-ZnO blends also displayed a
significantly higher tensile strength (p+,- < 0.05) than that of the 10% blends as well. This
trend was probably due to the number of potential dislocation sites within the SFCS-ZnO
scaffold sample increasing as the ZnO WT% increases. Thus, the higher the number of
inclusions generated by the addition of particles within the matrix gives a higher likelihood
of premature failure, which is observed in Figure 4.29 and Figure 4.30.
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Figure 4.29. Bar chart exhibiting average ultimate tensile strength of all individual
SFCS-ZnO blends
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Figure 4.30. Barchart illustrating differences in average ultimate strength among SFCSZnO blends of known ZnO weight percent.

During SFCS-ZnO scaffold preparations, microcracks and fractures may have formed
within the ring structure due to the removal of the extremely fragile ring specimens after
the lyophilization process. Unfortunately, the freeze-dried specimens did not simply fall
out of the mold upon removal, the mold required separation to ensure any damage to
samples was minimized. The inner mold cores required subtle removal steps to near
surgical precision to separate them from the internal diameter of the ring specimen to
ensure minimal damage. Upon removal from the molds, the fragility of the freeze-dried
samples noticeably increased with the higher concentrations of ZnO nanoparticles. This
would further strengthen the increased deviation of the average tensile strength values for
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the pure SFCS blends, possibly increasing the number of microcracks and fractures
introduced during demolding. In a uniaxial tensile test where the specimen is stretched,
the much weaker scaffold matrix experiences most the load while the particles separate
away from one another. However, if agglomeration occurs with an increase in ZnO particle
concentration, this behavior will be even more prominent.
Elastic modulus was calculated from the selected points of the linear region of the
stress-strain plot and placed into Equation (18). Figure 4.31 represents the average elastic
modulus of each individual SFCS-ZnO blend, where the data shows a trend of a reduction
in elasticity with the increase in ZnO nanoparticle concentration. Figure 4.32 reveals that
the pure SFCS blends exhibited significantly higher elasticity (p < 0.05) in comparison to
the 5% and 10 % SFCS-ZnO blends. The 2% and 5% SFCS-ZnO blends also show a
significantly higher elasticity (p+,- < 0.05) than that of the 10% blends as well. Gupta et al.
[60] experienced a similar moduli reduction phenomenon with their SFCS scaffolds with
dispersed emodin based nanoparticles ranging from 40 nm to 100 nm in size after
sonication.
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Figure 4.31. Bar chart exhibiting average elastic modulus of all individual SFCS-ZnO
blends
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Figure 4.32. Barchart illustrating differences in average elasticity among SFCS-ZnO
blends of known ZnO weight percent.

Elongation at failure was calculated from the collected stress-strain data,
representing the ratio between final length and initial length at failure of the SFCS-ZnO
specimen. Figure 4.33 represents the average elongation at failure of each individual
SFCS-ZnO blend. The individual data does not tend to show any trend in elongation with
the increase in ZnO nanoparticle concentration.
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Figure 4.33. Bar chart exhibiting average % elongation of all individual SFCS-ZnO
blends

Figure 4.34 reveals that the pure SFCS blends exhibited significantly higher elongation (p
< 0.05) in comparison to the 2%, 5% and 10 % SFCS-ZnO blends. Elongation at break
and ultimate tensile strength of the biocomposites demonstrated a reduction with an
increase in the ZnO nanoparticle filler concentration. Again, this is due to the increase in
defect sites with an increase in nanoparticle concentration. The pure SFCS blends display
a significantly higher elongation at break than the blends with ZnO nanoparticles.
Specifically, blends within the 2% and 5% WT%, show a general trend of an increase in
elongation at the 200-nm particle size and decreases with the 45 nm and 30 nm particles,
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respectively. A blend of 200 nm particles at a fixed WT% compared to 30 nm particles
will have far less potential defect sites due to the nominal number of actual particles
dispersed throughout the sample.

Figure 4.34. Barchart illustrating differences in average elongation among SFCS-ZnO
blends of similar ZnO weight percent.

Viscoelastic Testing
All materials exhibit some viscoelastic behavior. Metals typically display purely
elastic response at small deformations and plastically deform under large deformations,
which is commonly independent of time.
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By contrast, materials such as synthetic

polymers, wood, and human tissue and engineered biomaterials exhibit significant
viscoelastic effects at small and large deformations [61]. The SFCS-ZnO composite blends
demonstrated time dependent or viscoelastic response. This time dependence is primarily
due to the distinct molecular structure of the SF and CS biomaterials [50] [51] [52].

Stress Relaxation
A technique for characterizing the viscoelastic time dependent behavior of a
material is the stress relaxation test, where a constant strain is applied to an SFCS-ZnO
sample, at a rate 50 mm/min to constant strain values of 37.50%, 43.75%, 50.00%, 56.25%,
and 62.50% and held statically for the prescribed times noted in Section 3.3.4 (Figure 4.35
(Top)), with a typical resultant stress response is shown in Figure 4.35 (bottom).

It is

noted that the induced stress of the SFCS-ZnO blended materials increases with an increase
in applied strain, but relaxes over time while held at a constant strain.
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Figure 4.35. Representative plot of (Top) Strain – Time of the controlled cross head and
(Bottom) a typical stress – time plot of a SFCS-ZnO blended sample (30:70 – 30 nm –
2%).

Figure 4.36 represents the data shown in Figure 4.35 (bottom) as a stacked plot with the
maximum stress for each cycle at time zero. There are three viscoelastic phenomena
occurring within this plot that will be presented and discussed within the investigation; 1.)
The initial stress in the specimen induced by the rapid increase in strain during the
experiment, 2.) the rate at which the SFCS-ZnO blends relax while under a constant static
strain and 3.) the equilibrium stress at which the specimen reaches while under that constant
static strain.
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Figure 4.36. Plot of stress relaxation versus time of a 3070-30nm-2% blended sample.

Initial Stress
The maximum stress experienced by the SFCS-ZnO blended specimen for each
constant strain cycle is termed the initial stress. Figure 4.37 represents the average initial
stress for each blend consolidated into 3 bar charts, representing the initial stress of the
SFCS-ZnO blends with respect to ZnO WT%, ZnO particle size, and SFCS blend,
respectively. ANOVA was performed on the initial modulus data demonstrating that ZnO
WT% and ZnO particle size significantly affected the initial stress where pWT% = 0.05,
0.044, 0.037, 0.033, and 0.028; psize = 0.01, 0.006, 0.005, 0.004, and 0.004 for each strain
cycle, respectively. SFCS blend demonstrated no significance with respect to initial
modulus (p >> 0.05). Similar to the mechanical testing, the nanoparticles WT% and size
tend to have more of an affect on material performance.
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INITIAL STRESS (MPa)
INITIAL STRESS (MPa)
INITIAL STRESS (MPa)

Figure 4.37. Consolidated plots of initial modulus versus applied strain with respect to
(Top) ZnO WT%, (Middle) ZnO Size, and (Bottom) SFCS blend
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Relaxation Rate
When the presented Stress – Time data is plotted on a log-log scale (Figure 4.38),
the results demonstrate a linear trend, indicating that the relaxation curves can be
approximated via the power law equation

𝑦 = 𝐴𝑡 𝑛

(34)

where the slopes of the relaxation data curves are indicated by the power (n) of the data.
Thus, the magnitude of n indicates the rate of relaxation with respect to time and when the
data is fitted to a power trend line, a strong correlation is achieved (R2 > 99%) for each
applied strain case.

Figure 4.38. A log – log plot of stress relaxation versus time of 3070-30nm-2% blend.

Figure 4.39 represents the average relaxation rate for each blend consolidated into 3 bar
charts, Figure 4.39a, b and c represents the relaxation rate of the SFCS-ZnO blends with
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respect to ZnO WT%, ZnO particle size, and SFCS blend, respectively. ANOVA was
performed on the relaxation rate data demonstrating that there was no significant difference
in relaxation rate between ZnO WT% (p >> 0.05), ZnO particle size (p >> 0.05), and SFCS
blends (p >> 0.05). There was a significant difference in relaxation rate between the first
constant strain cycle (37.50%) and the other test cycles (p < 0.001). This difference is due
to the lack of material preconditioning for this experiment due to the MQuattro Controller’s
inability to programmatically handle the number lines of input for the multicycle relaxation
test preceded by the preconditioning cycle. By performing preconditioning on the test
specimens, the difference in relaxation rate may have been mitigated. This phenomenon
was observed by all tested samples. The relaxation rate stabilized for each subsequent
strain cycle after the first at the lowest applied strain. The relaxation rate essentially
remains linear throughout the tested strain range of 37.5% up to 62.5%, this is well above
the normal circumferential strain experienced by the pulmonary artery during distension in
a healthy individual. Thus, demonstrating viable functionality.
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Figure 4.39. Consolidated plots of relaxation rate versus applied strain with respect to
(Top) ZnO WT%, (Middle) ZnO Size, and (Bottom) SFCS blend

Equilibrium Stress
The relaxation or equilibrium stress experienced by the SFCS-ZnO blended
specimen for each constant strain cycle is shown in Figure 4.40, which represents the
average initial stress for each blend was also consolidated into is also presented in 3 bar
charts. The equilibrium stress of the SFCS-ZnO blends with respect to ZnO WT%, ZnO
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particle size, and SFCS blend, respectively, are presented. An ANOVA was performed on
the equilibrium stress data demonstrating that ZnO WT% and ZnO particle size
significantly affected the initial modulus where pWT% = 0.05, 0.044, 0.039, 0.031, and
0.025; psize = 0.003, 0.003, 0.003, 0.002, and 0.002 for each strain cycle, respectively.
SFCS blends demonstrated no significance with respect to initial modulus (p >> 0.05).
Similar to the initial stress data, as the applied strain increased as did the stress. Since the
relaxation rate is essentially linear and equal across all recorded samples, the equilibrium
stress also follows that trend of increasing with respect to applied strain cycle.
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Figure 4.40. Consolidated plots of equilibrium modulus versus applied strain with
respect to (Top) ZnO WT%, (Middle) ZnO Size, and (Bottom) SFCS blend
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Creep Testing
Other techniques for characterizing the viscoelastic time dependent behavior of the
SFCS-ZnO blended materials are creep and creep recovery tests, where a constant force is
applied to the SFCS-ZnO sample, at a rate 50 mm/min to constant force values of 5.0, 7.5
and 10.0 grams and held statically for the prescribed times noted in Section 3.3.5 (Figure
4.41 (Top)) with a typical strain response shown in Figure 4.42 (bottom). The induced
strain of the SFCS-ZnO blended materials increases as the applied stress increases over
time while held at the constant force.

Figure 4.43. Representative plot of (Top) Stress – Time and (Bottom) a typical strain –
time plot of a SFCS-ZnO blended sample (SFCS-3070-30NM-2%)
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Figure 4.44 and Figure 4.45 present stacked plots of the creep and creep recovery
data for the induced strain data shown in Figure 4.43 (bottom) with the initial induced strain
for each cycle at time zero. It is noted that there are four viscoelastic phenomena occurring
within this plot; 1.) The creep strain induced by the application of the constant force during
the experiment for each cycle, 2.) The creep recovery strain induced by the removal of the
applied constant force during the experiment, 3.) The rate of creep and rate of creep
recovery the SFCS-ZnO blends creep while under said constant force and upon removal,
4.) The residual strain within the SFCS-ZnO sample after the removal of the applied force.

Figure 4.44. Plot representing creep of a 3070-30NM-2% blended SFCS-ZnO sample
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Figure 4.45. Plot representing creep recovery of a 3070-30NM-2% blended SFCS-ZnO
sample

Creep Strain
The average creep experienced by the SFCS-ZnO blended specimens for each
constant force cycle is represented in 3 bar charts (Figure 4.46), which representing the
strain responses of the SFCS-ZnO blends with respect to ZnO WT%, ZnO particle size,
and SFCS blend, respectively. An ANOVA was performed on the creep strain data
demonstrating that ZnO WT%, ZnO particle size, and SFCS blend demonstrated no
significance with respect creep strain (p >> 0.05). Similar to the stress relaxation tests, the
first constant stress cycle resulted in a higher average strain value than that of the latter two
cycles due to the lack of preconditioning experienced by the sample due to the MQuattro
Controller’s inability to programmatically handle the number lines of input for the
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multicycle creep test preceded by the preconditioning cycle. This data shows that while
under a constant load a sample regardless of SFCS-ZnO blend can handle a maximum
induced strain of nearly 50%.
Creep resistance can be defined as a material's ability to resist any kind of distortion
when under a constant load over time. Ultimately, for optimum performance and maximum
lifetime of the SFCS-ZnO sample should have a high creep resistance (i.e. low deformation
under constant load). As seen in Figure 4.46, all samples tend to show similar resistance
to creep.
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Figure 4.46. Plot of creep strain with respect to (Top) ZnO WT%, (Middle) ZnO Size,
and (Bottom) SFCS blend
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Creep Recovery
The creep recovery strain experienced by the SFCS-ZnO blended specimens upon
the removal of each constant force cycle is also represented in 3 bar charts (Figure 4.47)
with the strain responses of the SFCS-ZnO blends presented as ZnO WT%, ZnO particle
size, and SFCS blend, respectively. An ANOVA was performed on the creep recovery
strain data demonstrating that the SFCS blend significantly affected the specimen recovery
where the p-values were pBLEND = 0.037, 0.035, and 0.010; for each force cycle. ZnO WT%
and ZnO particle size demonstrated no significance with respect creep recovery strain (p >>
0.05). This significance with respect to the SFCS blend is expected since the supporting
matrix is the SFCS scaffold with a dispersion of ZnO nanoparticles that when under tension
will typically separate. The SFCS matrix will induce contraction of the ring upon reduction
of the load allowing for recovery.
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Figure 4.47. Plot of creep recovery strain with respect to (Top) ZnO WT%, (Middle)
ZnO Size, and (Bottom) SFCS blend
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Creep Rate and Creep Recovery Rate
When the Strain – Time data from the creep experiments is plotted on a log Strain
– log Time scale (Figure 4.48 and Figure 4.49), the curves are linear, similar to the stress
relaxation data curves presented previously, indicating that the creep and recovery curves
can also be approximated with the power law equation. Thus, the slopes of the creep and
creep recovery data fitted to a power trend line show a strong correlation, with an R2 > 99%
for each applied force case for creep and an R2 > 94% for each applied force case for creep
recovery.
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Figure 4.48. A representative log – log plot of Strain – Time of a single creep strain data
set of 3070-30nm-2% blend.

Figure 4.49. A representative log – log plot of Strain – Time of a single creep recovery
strain data set of 3070-30nm-2% blend.
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Figure 4.50 represents the average rate of creep for each blend in 3 bar charts,
representing the rate of creep of the SFCS-ZnO blends with respect to ZnO WT% (Figure
4.50 (Top)), ZnO particle size (Figure 4.50 (Middle)), and SFCS blend (Figure 4.50
(Bottom)), respectively. An ANOVA was performed on the creep rate data demonstrating
that ZnO WT% significantly affected the specimen rate of creep where the p-values were
pZnO-WT%= 0.016, 0.004, and 0.005 for each force cycle; while SFCS blend significantly
affected the specimen for the 7.5 and 10 gram cycles (pblend = 0.020 and 0.022) respectively.
The ZnO particle size demonstrated no significant difference with respect to creep recovery
strain (psize = 0.480, 0.324, and 0.297).
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Figure 4.50. Plots of rate of creep with respect to (Top) ZnO WT%, (Middle) ZnO Size,
and (Bottom) SFCS blend
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Figure 4.51 presents the average rate of creep recovery for each blend in 3 bar
charts, representing the rate of creep recovery of the SFCS-ZnO blends with respect to ZnO
WT% (Figure 4.51 (Top)), ZnO particle size (Figure 4.51 (Middle)), and SFCS blend
(Figure 4.51 (Bottom)), respectively.

An ANOVA was performed on the data

demonstrating that ZnO WT% and SFCS blend significantly affected the rate of creep
recovery where the p-values were pZnO-WT%= 0.031, 0.016, and 0.011 and pBLEND = 0.006,
0.003 and 0.022 for each force cycle, respectively. The ZnO particle size demonstrated no
significance with respect creep recovery strain (psize = 0.763, 0.529, and 0.506).
Both rate of creep and rate of creep recovery were significantly affected by SFCS
blend and ZnO concentration. The underlying support matrix is the blended SFCS with a
dispersion of ZnO nanoparticles that when under tension will typically separate. When
stretched the SFCS matrix will induce contraction of the ring upon a reduction in the load
allowing for recovery.
When comparing the rate of creep to the rate of creep recovery, one observes that
the rate of creep recovery is approximately 5 times greater than that of the rate of creep.
This indicates that the sample returns to its initial unstressed state up to 5 times faster than
when it is under a constant load. This is an optimal situation for this device, when
comparing the loading scenario to vessel distension. The sample should recover from the
vessel distension to rapidly accommodate change to the near unstressed state.
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Figure 4.51. Plots of rate of creep recovery with respect to (Top) ZnO WT%, (Middle)
ZnO Size, and (Bottom) SFCS blend
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Residual Creep Strain
The residual creep strain experienced by the SFCS-ZnO blended specimens upon
the removal of each constant force cycle is also represented and consolidated into 3 bar
charts (Figure 4.46) with the strain responses for the SFCS-ZnO blends presented as ZnO
WT%, ZnO particle size, and SFCS blend, respectively. An ANOVA was performed on
the residual strain data demonstrating that the ZnO WT% and SFCS blend significantly
affected the specimen recovery where the p-values were pZnO% = 0.011, 0.017, and 0.028
and pBLEND = 0.000, 0.000, and 0.000; for each force cycle, respectively. The ZnO particle
size demonstrated no significance with respect creep recovery strain (pSIZE = 0.436, 0.344,
0.297) for each force cycle.
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Figure 4.52. Plot of residual creep strain with respect to (Top) ZnO WT%, (Middle) ZnO
Size, and (Bottom) SFCS blend

168

Electrical characterization of biocompatible piezo-composites
Shear Testing
Electrode displacement and SFCS-ZnO sample response was recorded for each test.
Three samples were tested from each SFCS blend (27 blends in total, excluding 70:30 –
10% ZnO, due to previously stated mixing issues). The test samples were 20 mm round
disks that were 2 mm in thickness. Figure 4.53 demonstrates what a typical SFCS-ZnO
Response – Displacement plot resembled. This particular plot represents a 70:30 SFCS
blend with 30 nm ZnO particles at 2% weight concentration.

Figure 4.53. Plot illustrating (Bottom) Electrode displacement (25% strain) and the (Top)
Response of a SFCS-ZnO blend (70:30 with 30 nm at 2% ZnO)
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All three frequency parameters were tested in sequence at a constant 25% strain,
starting from 0.6 Hz (left side of plot) to 1.2 Hz (middle of plot) to 2.4 Hz (right of plot).
Similar data was recorded and plotted for each strain permutation (5% and 10%) as well.
The voltage vs. time plot above clearly displays an electrical response induced by a change
in strain at each frequency. Kwon et. al. [61], Chen et. al. [62], and Park et. al. [63]
fabricated piezoelectric substrates consisting of PZT film, PZT nanorod and ZnO
nanoparticle dispersion in PDMS (0-3), respectively, which yielded similar results.
Specifically, Kwon et. al. exposed their developed thin film device to compression to
generate the electrical response shown in Figure 4.54, experiencing a sharp peak upon
application of the load and then release. While Chen et. al. and Park et. al. exposed their
developed nanorod device and 0-3 soft nanoparticle device, respectively, to bending for
generating the electrical responses shown in Figure 4.55 and Figure 4.56, which also
yielded a sharp peak upon application of the load and then release. The response of the
SFCS-ZnO blends have similarities to the aforementioned piezoelectric devices which
demonstrates the efficacy of the soft bio-device.
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Figure 4.54. Piezoelectric response to of a flexible film device comprised of PZT [61]

Figure 4.55. Piezoelectric response to bending nanorod device comprised of PZT [62].

Figure 4.56. Piezoelectric response to bending a 0-3 nanoparticle composite based device
comprised of ZnO dispersed within PDMS [63]
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The Strain-Response data was compiled in a custom MatLab Peak Detection script
(Appendix C.2) that would detect the average Peak-to-Peak value for each set of strain data
at each individual frequency. This average peak-to-peak data was then inputted into a
Microsoft Excel script for further analysis and plotted for side-by-side comparison to the
other blends.
Plots shown in Figure 4.57 through Figure 4.65 display the actual electrical
responses of the SFCS-ZnO blends with no gain used at all frequency and strain
permutations. For each SFCS-ZnO blend, an increase in the strain experienced by the
blend generated an increase in specimen response. Of the 27 total blends that were tested
in this study, only 4 demonstrated a significantly higher response to the applied strain. As
shown in Figure 4.58 and Figure 4.61, the 5% weight concentrations for the 30:70 and
50:50 blends comprised of 30 and 45 nm ZnO nanoparticles exhibited a higher response to
the applied strain than any of the other SFCS-ZnO blends, including the control pure SFCS
blends. A goal of this specific experiment was to narrow down which blends have the
highest response to strain in order to reduce the number of blends included in the distension
tests.
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Figure 4.57. Barchart of 2%-30 nm SFCS-ZnO response to 5%, 10%, and 25% shear
strain at 0.6, 1.2 and 2.4 Hz.

Figure 4.58. Barchart of 5%-30 nm SFCS-ZnO response to 5%, 10%, and 25% shear
strain at 0.6, 1.2 and 2.4 Hz.

Figure 4.59. Barchart of 10%-30 nm SFCS-ZnO response to 5%, 10%, and 25% shear
strain at 0.6, 1.2 and 2.4 Hz.
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Figure 4.60. Barchart of 2%-45 nm SFCS-ZnO response to 5%, 10%, and 25% shear
strain at 0.6, 1.2 and 2.4 Hz.

Figure 4.61. Barchart of 5%-45 nm SFCS-ZnO response to 5%, 10%, and 25% shear
strain at 0.6, 1.2 and 2.4 Hz.

Figure 4.62. Barchart of 10%-45 nm SFCS-ZnO response to 5%, 10%, and 25% shear
strain at 0.6, 1.2 and 2.4 Hz.
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Figure 4.63. Barchart of 2%-200 nm SFCS-ZnO response to 5%, 10%, and 25% shear
strain at 0.6, 1.2 and 2.4 Hz.

Figure 4.64. Barchart of 5%-200 nm SFCS-ZnO response to 5%, 10%, and 25% shear
strain at 0.6, 1.2 and 2.4 Hz.

Figure 4.65. Barchart of 10%-200 nm SFCS-ZnO response to 5%, 10%, and 25% shear
strain at 0.6, 1.2 and 2.4 Hz.
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Figure 4.66 displays the actual electrical response of the pure SFCS blends at all
frequency and strain permutations. The maximum response for any of the pure blends did
not exceed 750 µV. Silk fibers and silk fibroin are naturally piezoelectrics, as are many
other naturally occurring materials, such as quartz and bone. Under well controlled testing
conditions with high precision measurement equipment, natural silk fibers can generate a
voltage difference of up to 20 millivolts when stressed [64]. The electrical response of the
pure SFCS blends were lower than that of most SFCS-ZnO blends tested in this
investigation, especially the 4 selected for the distension trials.

Figure 4.66. Barchart of pure SFCS sample response to 5%, 10%, and 25% shear strain
at 0.6, 1.2 and 2.4 Hz.

Frequency Dependence
There is a noticeable effect of the measured SFCS blend sample response with
respect to the applied shaker frequency. The output voltage amplitude is reduced when the
applied frequency increases. This effect is due to the soft SFCS- blended samples’ inability
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to respond at the same rate as the applied external mechanical strain, which dampens the
overall magnitude of the external force. Xu et al. [65] experiences this same phenomenon
with PZT nanowire arrays within an epoxy matrix which they employed for energy
scavenging at considerably low frequencies. An additional possibility of this frequency
dependent response may be due to the tested material experiencing mechanical
preconditioning as the sample is being tested. With each increase in frequency, the sample
experiences an additional level of mechanical conditioning. This phenomenon in alongside
the structural latency of the scaffold matrix contribute to the reduction in output of the
sample.

Figure 4.67. Plot representing frequency dependent reduction in electrical response [65]

Poling Study
A study of poling of the SFCS-ZnO blended materials and its effectiveness was
performed to assess whether the procedure would affect electrical response of the selected
materials from the study performed in Section 4.3.1. The poling electrodes were fabricated
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and assembled with all components described in Section 3.2.3. The gap between the
electrodes was set to 2 mm. The wet SFCS-ZnO samples were placed equidistant from
one another in the poling assembly, loading no more than 3 samples per poling procedure,
and allowing for a center-to-center spacing of approximately 30 mm between samples.
Around 15 minutes into the poling procedure stated in Chapter 3, arcing across the
electrodes would occur at driving voltages as low as 2 kilovolts. Damage to the specimen,
poling electrode assembly, and high voltage power supply occurred during the poling
process. Figure 4.68 demonstrates the damage that occurred on the electrode (upper inset)
and the specimen (lower inset). To prevent a total loss of the piece of equipment, testing
was halted due to excessive damage to the high voltage power supply resulting in
substantial repairs to the internal instrumentation by the investigator and resident experts.
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Figure 4.68. Image of damage resulted via applying a high voltage to the poling
electrode assembly.

In Vitro Testing of SFCS-ZnO Blends in Mock Vessel Models
Compliance and Circumferential Strain Testing
Mechanical characteristics such as compliance and circumferential strain were
calculated from the recorded diameters of porcine aorta tissue and the engineered analog
tubes constructed from an elastomeric polymer (DragonSkin®). These values were critical
in determining the relationship between the applied pressure via the Custom
Electrodynamic Vessel Distension Simulation Apparatus to determine the required platen
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stroke to achieve the desired pulse pressure ranges. Table 4.6 and Table 4.7 present the
calculated compliance and circumferential strains attained in response to simulated
diastolic and systolic pressures. Three different systolic pressures were applied to the
elastomeric tubes and porcine aortas with the diastolic pressures held constant. Varying
the systolic pressure and leaving the diastolic pressure at a constant 70 mmHg for each test
set was determined to be the simplest method since it was easier to increase the systolic
pressure within the vessel by changing the stroke of the EDS, while maintaining the
baseline diastolic pressure that was driven by the initial injection of saline into the VAS.
The relationship between the applied pressure and the compliance and circumferential
strain were critical in determining the required platen stroke for achieving the desired pulse
pressure ranges of the EVDSA.
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Table 4.6. List of compliance and circumferential strain data calculated from measured
vessel diameters from an engineered tube comprised of DragonSkin®.

Applied Pressure
Psys

Pdia

(mmHg) (mmHg)

Measured
Diameter

Compliance

Circumferential
Strain

Dsys

Ddia

C

εD

(mm)

(mm)

(mmHg-1)

(mm/mm) %

140

70

13.30

11.2

0.0027

21%

120

70

12.32

11.2

0.0020

11%

100

70

11.74

11.2

0.0016

5%

Table 4.7. List of compliance and circumferential strain data calculated from measured
vessel diameters from a 15 kg pig aorta.

Applied Pressure
Psys

Pdia

(mmHg) (mmHg)

Measured
Diameter

Compliance

Circumferential
Strain

Dsys

Ddia

C

εD

(mm)

(mm)

(mmHg-1)

(mm/mm) %

140

70

14.02

11.45

0.0032

23%

120

70

12.80

11.45

0.0024

12%

100

70

12.30

11.45

0.0024

7%

The changes in diameter due to vessel pressure were plotted for both the engineered
Dragonskin® tube and the descending aorta of the 15 kg pig (Figure 4.69). The applied
pressure ranged from 70 to 140 mmHg that resulted in a change in diameter of 2.58 mm
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and 2.10 mm for the porcine aorta and Dragonskin®, respectively. The goal was to mimic
the mechanical behavior of the aortic tissue during distension with the more accessible off
the shelf Dragonskin® resin. The distinct difference between the two vessels is the
difference in diameters at each applied pressure value (Figure 4.69). The engineered vessel
was fabricated within a mold with a nominal diameter of 10 mm, which was the inner
diameter of an off the shelf tube that was cheap and readily available for use. This
dimension could not be easily changed without the use of a custom manufactured mold.
The aorta was on average 13.6±0.8% larger in diameter at each applied pressure, primarily
because the aorta was larger in diameter. Notice the undulations in the aorta curve versus
the engineered tube. This was due to the aorta not having homogenous material properties
throughout its length or circumference, whereas, the elastomeric tube had a much higher
level of homogeneity throughout, generating a smoother curve. Also, the slope of each
curve is quite similar as well, 0.030x and 0.035x for the Dragonskin and aorta, respectively,
with both having an R2 = to 95.5%.
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Figure 4.69. Diameter – Pressure plot of engineered Dragonskin vessel and a 15 kg
porcine aorta.

Figure 4.70 demonstrates the similarities in changes in circumferential strain due to vessel
pressure between the engineered Dragonskin® tube and the descending aorta of the 15 kg
pig.

The applied pressure ranged from 70 to 140 mmHg for the porcine aorta and

Dragonskin®, respectively.

The curves have striking similarities with respect to

circumferential strain and nearly overlap one another; indicating how well the engineered
tube approximated the mechanical behavior of the porcine aorta. Thus, the DragonSkin®
vessels were used for initial testing of the ring samples in order to determine the optimum
placement of the electrodes in the SFCS-ZnO ring samples before performing the porcine
aorta tests.
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Figure 4.70. Circumferential Strain – Pressure plot of engineered Dragonskin vessel and
a 15 kg porcine aorta.

Electrode Placement Investigation
Upon completion of the shear testing and identification of the 4 top performing
SFCS-ZnO blends, the ring-shaped samples were placed on the DragonSkin® vessels.
Three samples of the 50:50 SFCS-ZnO blend with 45 nm particle at a 5% concentration
were used to identify the optimum electrode placement by investigating 6 different
electrode positions and configurations, as previously described in Section 3.3.3.3.
Electrode placement and SFCS-ZnO sample response was recorded for each test. The EDS
platen stroke, internal vessel pressure induced by said change in platen stroke, and the
measured voltage generated by the distended SFCS-ZnO sample were plotted (Figure
4.71). The programmed square wave input into the EDS controller-amplifier induced a
square wave pressure response profile. The initial impulse experienced by the pressure
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sensor was a rapid increase that resulted in an overshoot in the pressure. This overshoot
was likely due to the small internal closed volume of the test apparatus and the pressure
waves irradiating from the piston and traveling along the inner volume of the tube, induced
by the rapid change in stroke. The change in SFCS-ZnO response corresponded to the
change in pressure, whereas the vessel distended, and the ring sample experienced an
increased state of tension. The electrical response of the samples, while in the state of
tension resulted in a negative peak due the local polarization of the SFCS-ZnO sample that
was loaded. ZnO was naturally polarized, therefore it did not require high voltage
polarization to generate a piezoelectric output. If the natural polarization negates the
applied force then the resultant output will have a negative charge. Alternatively, when
the vessel returns to its diastolic state via rapid reduction in applied pressure, the ring
experiences compression during the rapid return to its original state and a positive electrical
output peak was observed. The highly porous nature of the SFCS scaffold and the low
stiffness made the 0-3 piezocomposite tend to have a higher affinity for compressive loads.
As the scaffold was stretched via tensile forces the intricate matrix elongated; thus, it was
difficult to apply a tensile force directly onto the nanoparticles themselves due to the weak
to no binding between the SFCS matrix and the nanoparticles. Whereas, when under a
compressive load, the porous matrix collapses, the SFCS scaffold which then exuded a
direct compressive load onto the nanoparticles as well as increased the particle-to-particle
interaction of the ZnO. This type of result was also experienced by [63] through the
continual stretching and relaxing of 0-3 type piezoelectric materials. As seen in the shear
testing data from Section 4.3.1, a reduction in electrical response was observed as
frequency increased.
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Figure 4.71. 5050-45nm-2%, 180 degree axial position, with amplification.

As mentioned previously, SFCS-ZnO ring sample response with respect to
electrode position, pulse pressure range, and frequency were also investigated (Figure
4.72). The data demonstrated that the 180˚ axial electrode configuration had a higher
response compared to the other two axial configurations (with angular positions 45˚ and
90˚) and radially (at 180˚ position) configured electrodes. The 180˚ position accounted for
a nominal electrode distance of approximately 22.0 mm. The change in the noted variables
accounted for the reduction in electrical response. The angular distance between the wire
electrodes for the 180˚ axial position generated the highest due to the greater number of
piezoelectric nanoparticles between the electrodes.

Whereas, the 45˚ and 90˚

configurations would, in theory, have had 25% and 50% less nanoparticles, respectively,
due to the shorter distance between the electrodes. Additionally, the orientation of the wire
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while inserted into the SFCS-ZnO sample influenced the response of the sample as well.
Specifically, the axial orientation effectively had double the contact surface area (12.56
mm2) for the electrode within the SFCS-ZnO sample in comparison to the radial
orientations (6.28 mm2). This point was further supported by the output response results
where the radial orientation displayed a lower response than the axial orientation, albeit
not significant.

Figure 4.72. Bar chart demonstrating output of SFCS ring samples wire electrodes
placed at 45˚, 90˚, and 180˚ oriented in both axial and radial configurations with respect
to the vessel geometry.

Ex vivo testing of SFCS-ZnO samples on excised porcine aorta
Upon completion of the electrode placement investigation, the 4 top performing
SFCS-ZnO blends were then placed on excised descending aortas from 15 kg
Yorkshire/Landrace pigs. The electrode wires were oriented in the 180˚ axial position.
Similar to the electrode placement studies, the EDS platen stroke, measured internal vessel
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pressure, and the measured output voltage generated by the distended SFCS-ZnO blends
data was recorded and plotted. Like the in vitro elastomer-based tubes, the change in SFCSZnO response corresponded to the change in pressure (Figure 4.73). In addition, the peakto-peak response data for the SFCS-ZnO ring samples with respect to electrode position,
pulse pressure range, and frequency were plotted (Figure 4.74). Of the 4 SFCS-ZnO blends
tested, the observed data demonstrated that the 3070 SFCS blend with the 30 nm ZnO
nanoparticles at a ZnO concentration of 5% by weight exhibited the highest response
during distension. The average Elastic Modulus of the 4 tested SFCS-ZnO candidates was
also presented in Figure 4.74, shown as large black circles with the error bars denoting
standard deviation. This demonstrated a correlation between the mechanical stiffness of
the SFCS-ZnO matrix and the electrical response of the material.

Thus, this final

experiment proved that the SFCS tissue scaffolds with embedded ZnO nanoparticles do
provide the capability to act as a piezoelectric pressure sensor under cardiovascular
physiological conditions.
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Figure 4.73. Plot of shaker stroke (Top), vessel pressure (Middle), and SFCS response
(Bottom) for a 3070-45nm -5% sample

Figure 4.74. Bar chart demonstrating output of SFCS ring samples when mounted to
porcine aortic tissue and distended.

189

CHAPTER 5:

CONCLUSIONS

The goal of this project was to develop and create prototype biocompatible and
bioresorbable electroactive perivascular bands comprised of several permutations of SFCS
blends, ZnO nanoparticle size and ZnO nanoparticle concentrations. Mechanical and
electrical studies were performed to determine the optimal blend of scaffold with respect
to ZnO nanoparticle concentration. Demonstration and advancement of said prototypes
would not have been possible without the development of:


Molds for production of all SFCS-ZnO test samples



A custom-designed differential amplification circuit with electronics chosen for
easy gain adjustment and low-noise



Supporting data acquisition and analysis software to set the response offsets,
control sampling, and record the experimental data



A custom dynamic material shearing unit



A custom dynamic distension unit
Collectively, the aforementioned individual components provided experimental

platforms to explore the mechanical and electrical performance of the SFCS-ZnO blends.
Evaluation of the electronics indicated that the performance of the amplification circuit fell
within specifications and functioned as designed. The data acquisition and analysis
software developed was an essential component for both experimental control as well as
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post experiment data processing methods. The custom dynamic shearing and distension
units proved vital in the determination of electrical response of the SFCS-ZnO samples
when exposed to mechanical shear strains and circumferential strains induced via vessel
distension. This investigation established that a fully functional biocompatible material
can be doped with a biocompatible piezoelectric nanoparticle and demonstrate a means of
converting mechanical strain into a measurable electrical signal output without the need of
power or external wiring of any kind.
Based on the present investigation and current understanding of the functionality of the
newly developed tissue engineered perivascular sensor, the following recommendations
are made with respect to future work:
1. Take a deeper look into the actual piezoelectric characteristics of the device.
Potentially determining and gaining a greater understanding of the principles
behind the scenes.
2. Develop a perivascular band that goes beyond the proof of concept solid ring
structure which currently cannot be surgically placed around a desired blood vessel.
A method of securely wrapping a flat strap band design, similar to a wristwatch
band, would be required for proper surgical installation of the device.
3. Develop an implantable electrode that interfaces with the tissue engineered scaffold
more effectively than the current simple electrode wire approach used in this study.
4. Perform an acute in vivo animal experimentation to confirm device robustness to
survive surgical implantation and short term efficacy of the device. Determine
whether the device functions while under normal physiological conditions in vivo.
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Perform a chronic in vivo animal experimentation to determine long term efficacy of the
device. This study would 1.) determine the body’s response to the implanted device over
time and 2.) discover whether the electrical response degrades or improves as the body
incorporates the tissue scaffold into the vessel wall.
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Appendix 1 – Mechanical Drawings and Bill of Materials
Custom Electrodynamic Biaxial Testing Apparatus
A custom frame was designed and fabricated to be mounted directly to the EDS
steel frame. The lasercut acrylic sheets (6.34 mm thick) were designed to be bolted to the
EDS u-channel support and isolation structure which is located under the shaker unit. A
rack and pinion mechanism is mounted to the top of the acrylic frame within a housing
block allowing for 0.005 inches per degree of rotation of fine adjustment through the knob.

Figure 0.1. Biaxial testing apparatus

A biaxial testing apparatus was custom designed to effectively stretch test coupons
equally in both the X and Y directions. This device was intended to be directly mounted
to the rack of the fine adjustment mechanism and the platen of the electrodynamic shaker
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unit shown in Figure 0.1. The maximum equibiaxial strain the apparatus is designed to
transmit to the test sample is 40%. The biaxial apparatus consists of 3 parallel sheets of
lasercut 1.5 mm thick Delrin© sheet. The two outermost sheets convert the uniaxial
displacement delivered by the EDS into equibiaxial displacement. The symmetric structure
of the “cross” effectively performs this task. There are eight shoulder bolts (Ø3 mm) that
connect the equibiaxial cross structure to the innermost “snowflake” structure,5 mm long
standoffs center the snowflake structure equally between the outer “cross” sheets. The
inner geometry of the snowflake converges to a 10 mm square with 16 electrodes with a
span of 2.5 mm.

Figure 0.2. Custom built biaxial testing apparatus.
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Figure 0.3. Exploded view of custom built biaxial testing apparatus.

In order to load a SFCS blended sample the user must physically press the puncture
the scaffold via the electrode pins on the “snowflake” component of the biaxial unit. This
puncturing process initiated localized fracture sites at each electrode location with the
sample. Upon displacing the biaxial device with a loaded sample, the localized fracture
sites within the SFCS sample would propagate along the dynamic path of each of the
electrode locations. This loss of mechanical integrity would compromise the electrical
response of the SFCS sample. An alternative approach to a controllable input displacement
was required.
Biaxial electrode mold
The biaxial electrode mold (Figure 0.4) was manufactured to allow for precise
injection of ecoflex:ZnO blends into the desired form to be mounted in the biaxial testing
apparatus. This mold is laser cut from 4 separate layers of acrylic and Delrin. The base
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layer (Figure 0.4b-(a)) is comprised of acrylic, is 0.250 inches thick and has threaded holes
to allow for all other layers to be securely clamped together. Layer (b) is comprised of
1/16 inch Delrin and has hole arrays that correspond to the spans of the electrodes in the
biaxial testing apparatus (BTA). Layer (c) is comprised of 1 mm thick Delrin and accounts
for the overall volume of the test sample coupon geometry, it also has internal channels to
allow for the flow of uncured resin to fill multiple cavities within the mold. Layer (d) is
comprised of 1/8 inch thick acrylic and houses the array of mold pins (e) that again
correspond to the BTA electrodes spans. The mold pins create the holes in the sample that
allow for easy sample mounting in the BTA and are pressed in for a secure and repeatable
filling of material.
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e
d

c
b

a

Figure 0.4. a.) CAD rendering of biaxial electrode mold. b.) CAD rendering of test
sample
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Shear Apparatus
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Distensio Apparatus
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Appendix 2 - Electrical Drawings and Bill of Materials

DIFFERENTIAL AMPLIFIER BOM
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Appendix 3 - Program Algorithms and Code
MATLAB PLOTTING SCRIPT
%% SELECTING MULTIPLE FILE DIRECTORY

s = dir(*.txt');
%s = dir(*.txt');

names = {s.name};
nr = 5; % # of rows
nc = 5; % # of columns
mat = zeros(nr,nc);

for n = 1:numel(names)
data = dlmread([‘’\' names{n}]);
%data = dlmread(['' names{n}]); %for lab PC

%% FILE INPUT

%dataname = '15APR2015-2-ZNO%-200-NM-ECO--S1-R1-6.txt';
%data = dlmread(dataname);
%timename = 'SAMPLE-RATE-100KP.txt';
%time = dlmread(timename);

response = data(:,1);
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input = data(:,2);

%% STRING MANIPULATION FOR FILE SAVING

path = '’;
filename1 = strrep(names{n},'.txt','');
filename2 = '_PLOT1';
filename3 = '_PLOT2';
filename4 = '_PLOT3';
filename5 = '_PLOT4';
filename6 = '_PLOT5';
filename7 = '_PLOT6';
filename8 = '_PLOT7';

%% TIME DATA

numpoints = length(response);
rate = 5000;
time = (numpoints/rate)-(1/rate);
t = transpose(0:1/rate:time);
x = transpose(0:1:numpoints-1);
xx = numpoints;

%% PLOT 1
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f1 = figure;
subplot(2,1,1);
plot(x,response,'Color','r','LineWidth',1)
ylabel 'Voltage (V)', xlabel 'Time (s)'
title 'Signal Response',
axis([0 xx -1.0 1.0])
subplot(2,1,2);
plot(x,input,'Color','b','LineWidth',1)
ylabel 'Displacement (in)', xlabel 'Time (s)'
title 'Input Signal',
axis([0 xx .28 0.37])

fig1 = strcat(filename1,filename2,'.fig');
jpg1 = strcat(filename1,filename2,'.jpg');
saveas(f1,fig1);
saveas(f1,jpg1);

close
end
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MATLAB PEAK TO PEAK DETECTION AND ANALYSIS
%% SELECTING MULTIPLE FILE DIRECTORY

s = dir(*.txt');
names = {s.name};

all_data = [];
for n = 1:numel(names)
data=designfilt('highpassiir','FilterOrder',8,'PassbandFrequency',0.45,'PassbandRipple',0.2
,'SampleRate',2000);

buttfilter = filtfilt(hpFilt,response);

%% PEAK 2 PEAK HEIGHT

FQ1 = peak2peak(buttfilter(10000:30000));
OF INNER 50% OF SINGLE AT 0.6 HZ

%PEAK TO PEAK MEASUREMENT

FQ2 = peak2peak(buttfilter(37000:47000));
OF INNER 50% OF SINGLE AT 1.2 HZ

%PEAK TO PEAK MEASUREMENT

FQ3 = peak2peak(buttfilter(52000:59000));
OF INNER 50% OF SINGLE AT 2.4 HZ

%PEAK TO PEAK MEASUREMENT

F = [FQ1;FQ2;FQ3];
all_data(n).data = F;

end
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FF = struct2cell(all_data);
FFF = cell2mat(FF);
dlmwrite(','\t')
DISTENSION DATA SCRIPT
%% SELECTING MULTIPLE FILE DIRECTORY
s = dir(*.txt');

names = {s.name};
for n = 1:numel(names)
data = dlmread(['' names{n}]);

%% FILE INPUT

%dataname = '15APR2015-2-ZNO%-200-NM-ECO--S1-R1-3.txt';
%data = dlmread(dataname);
%timename = 'SAMPLE-RATE-100KP.txt';
%time = dlmread(timename);

response = data(:,3);
pressure = data(:,2);
input = data(:,1);

%% STRING MANIPULATION FOR FILE SAVING
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filename1 = strrep(names{n},'.txt','');

%% TIME DATA

numpoints = length(response);
rate = 2000;
time = (numpoints/rate)-(1/rate);
t = transpose(0:1/rate:time);
x = transpose(0:1:numpoints-1);
xx = numpoints - 1;

%% PLOT 1

figure
% subplot(2,1,1);
% plot(x,response,'Color','r','LineWidth',2)
% ylabel 'Voltage (V)', xlabel 'Time (s)'
% title 'Signal Response',
% axis([0 xx -5 0])
% subplot(2,1,2);
% plot(x,input,'Color','b','LineWidth',2)
% ylabel 'Displacement (in)', xlabel 'Time (s)'
% title 'Input Signal',
% axis([0 xx 0.06 0.1])
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% axis([0 xx -5.0 5.0])

%% FILTERING 60 HZ NOISE

hpFilt = designfilt('highpassiir','FilterOrder',8, ...
'PassbandFrequency',0.45,'PassbandRipple',0.2, ...
'SampleRate',2000);

buttfilter = filtfilt(hpFilt,response);
buttfilterP = filtfilt(hpFilt,pressure);

% plot(buttfilterP,buttfilter,'Color','r','LineWidth',.5)
% ylabel 'Voltage (V)', xlabel 'Time (s)'
% title 'SFCS Response',

% PLOT #2
figure
plot(x,response,x,buttfilter)
ylabel 'Voltage (V)', xlabel 'Time (s)'
title 'Unfiltered vs. Filtered', legend('Unfiltered','Filtered')
% axis([0 xx -0.5 0.5])

figure
plot(x,pressure,x,buttfilterP)
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ylabel 'Voltage (V)', xlabel 'Time (s)'
title 'Unfiltered vs. Filtered', legend('Unfiltered','Filtered')

%PLOT #4
% f1 = figure(1);
%
% subplot(5,1,1);
% plot(x,input,'Color','b','LineWidth',.5)
% ylabel 'Displacement (in)', xlabel 'Time (s)'
% title 'Shaker Stroke',
% axis([0 xx 0 0.5])
%
% subplot(5,1,3);
% plot(x,pressure,'Color','g','LineWidth',.5)
% ylabel 'Pressure (mmHg)', xlabel 'Time (s)'
% title 'Vessel Pressure',
% axis([0 xx 0 180])
%
% subplot(5,1,5);
% plot(x,buttfilter,'Color','r','LineWidth',.5)
% ylabel 'Voltage (V)', xlabel 'Time (s)'
% title 'SFCS Response',
% axis([0 xx -1.0 1.0])
%
% suptitle(filename1);
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%
% fig1 = strcat(filename1,'.fig');
% jpg1 = strcat(filename1,'.jpg');
% saveas(f1,fig1);
% saveas(f1,jpg1);

%%
% NFFT = 2^nextpow2(numpoints); % Next power of 2 from length of y
% Y = fft(response,NFFT)/numpoints;
% f = rate/2*linspace(0,1,NFFT/2+1);
%
% % Plot single-sided amplitude spectrum.
% plot(f,2*abs(Y(1:NFFT/2+1)))
% title('Single-Sided Amplitude Spectrum of y(t)')
% xlabel('Frequency (Hz)')
% ylabel('|Y(f)|')
% axis([0 3.2 0 .2])

End
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Appendix 4 – Experimental Data
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SEM Imagery
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Stress versus strain plot for a single sample of each SFCS-ZnO blend.

Mechanical Testing of 15 kg porcine descending aortic tissue

233

Mechanical Testing of 15 kg porcine descending aortic tissue in tensile tester
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Preconditioning cycle of 15 kg porcine descending aortic tissue
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Mechanical Data from 15 kg porcine descending aorta tissue tensile tests.
10.878 ± 0.3096
E
Mpa
ETOE

0.391

± 0.0344

Mpa

σUT

4.916

± 0.1328

Mpa

%εBREAK

2.003

± 0.0917 mm/mm

σY

4.650

± 0.2900
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3
3
1
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